UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 20222023

remarkholdingslogo.jpg
Commission File Number 001-33720

Remark Holdings, Inc.
Delaware33-1135689
State of IncorporationIRS Employer Identification Number

800 S. Commerce St.
Las Vegas, NV 89106

Address, including zip code, of principal executive offices

702-701-9514

Registrant’s telephone number, including area code


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 par value per shareMARKThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

As of November 11, 2022,17, 2023, a total of 106,407,76920,931,855 shares of ourthe issuer’s common stock were outstanding.



TABLE OF CONTENTS

PART I
Item 1.
Item 2.
Item 3.
Item 4.
PART II
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.



SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

The matters discussedfollowing information should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q (this “Form 10-Q”) includeand our audited consolidated financial statements and related notes included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (the “SEC”) on April 17, 2023 (the “2022 Form 10-K”).

In addition to historical information, this Form 10-Q includes “forward-looking statements” about the plans, strategies, objectives, goals or expectations of Remark Holdings, Inc. and subsidiaries (“Remark”, “we”, “us”, “our”). You will find forward-looking statements principally in the sections entitled Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of OperationsOperations.. Such forward-looking statements are identifiable by words or phrases indicating that Remark or management “expects,” “anticipates,” “plans,” “believes,” or “estimates,” or that a particular occurrence or event “will,” “may,” “could,” “should,” or “will likely” result, occur or be pursued or “continue” in the future, that the “outlook” or “trend” is toward a particular result or occurrence, that a development is an “opportunity,” “priority,” “strategy,” “focus,” that we are “positioned” for a particular result, or similarly-stated expectations. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report or such other report, release, presentation, or statement. The forward-looking statements contained in this Form 10-Q are based on the expectations, estimates, projections, beliefs, and assumptions of our management based on information available to management as of the date on which this Form 10-Q was filed with the SEC, or as of the date on which the information incorporated by reference was filed with the SEC, as applicable, all of which are subject to change. Forward-looking statements are subject to risks, uncertainties, and other factors that are difficult to predict and could cause actual results to differ materially from those stated or implied by our forward-looking statements.

In addition to other risks and uncertainties described in connection with the forward-looking statements contained in this report and other periodic reports filed with the Securities and Exchange Commission (“SEC”),SEC, there are many important factors that could cause actual results to differ materially. Such risks and uncertainties include general business conditions, changes in overall economic conditions, our ability to integrate acquired assets, the impact of competition and other factors which are often beyond our control.

This should not be construed as a complete list of all of the economic, competitive, governmental, technological and other factors that could adversely affect our expected consolidated financial position, results of operations or liquidity. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may impair our business, operations, liquidity, financial condition and prospects. We undertake no obligation to update or revise our forward-looking statements to reflect developments that occur or information that we obtain after the date of this report.




PART I FINANCIAL INFORMATION
ITEM 1.    FINANCIAL STATEMENTS

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(dollars in thousands, except share and per share amounts)
September 30, 2022December 31, 2021September 30, 2023December 31, 2022
(Unaudited)(Unaudited)
AssetsAssetsAssets
CashCash$376 $14,187 Cash$270 $52 
Trade accounts receivable, netTrade accounts receivable, net5,753 10,267 Trade accounts receivable, net3,043 3,091 
Inventory, netInventory, net1,545 1,346 Inventory, net455 308 
Investment in marketable securities— 42,349 
Deferred cost of revenueDeferred cost of revenue5,630 589 Deferred cost of revenue5,899 7,463 
Prepaid expense and other current assetsPrepaid expense and other current assets1,550 5,774 Prepaid expense and other current assets801 1,374 
Total current assetsTotal current assets14,854 74,512 Total current assets10,468 12,288 
Property and equipment, netProperty and equipment, net1,404 357 Property and equipment, net1,106 1,699 
Operating lease assetsOperating lease assets118 194 Operating lease assets678 180 
Other long-term assetsOther long-term assets312 440 Other long-term assets146 269 
Total assetsTotal assets$16,688 $75,503 Total assets$12,398 $14,436 
LiabilitiesLiabilitiesLiabilities
Accounts payableAccounts payable$9,202 $10,094 Accounts payable$8,578 $9,602 
Advances from related partiesAdvances from related parties870 — Advances from related parties1,030 1,174 
Obligations to issue common stockObligations to issue common stock9,184 1,892 
Accrued expense and other current liabilitiesAccrued expense and other current liabilities6,570 5,963 Accrued expense and other current liabilities9,353 7,222 
Contract liabilityContract liability293 576 Contract liability363 308 
Notes payable, net of unamortized discount and debt issuance cost of $2,189 at December 31, 202114,418 27,811 
Notes payable (past due)Notes payable (past due)16,472 14,607 
Total current liabilitiesTotal current liabilities31,353 44,444 Total current liabilities44,980 34,805 
Operating lease liabilities, long-termOperating lease liabilities, long-term25 25 Operating lease liabilities, long-term336 56 
Total liabilitiesTotal liabilities31,378 44,469 Total liabilities45,316 34,861 
Commitments and contingenciesCommitments and contingenciesCommitments and contingencies
Stockholders’ Equity (Deficit)
Stockholders’ DeficitStockholders’ Deficit
Preferred stock, $0.001 par value; 1,000,000 shares authorized; zero issuedPreferred stock, $0.001 par value; 1,000,000 shares authorized; zero issued— — Preferred stock, $0.001 par value; 1,000,000 shares authorized; zero issued— — 
Common stock, $0.001 par value; 175,000,000 shares authorized; 106,407,769 and 105,157,769 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively106 105 
Common stock, $0.001 par value; 175,000,000 shares authorized; 19,711,855 and 11,539,564 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectivelyCommon stock, $0.001 par value; 175,000,000 shares authorized; 19,711,855 and 11,539,564 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively20 12 
Additional paid-in-capitalAdditional paid-in-capital366,263 364,239 Additional paid-in-capital378,022 368,945 
Accumulated other comprehensive lossAccumulated other comprehensive loss(1,137)(270)Accumulated other comprehensive loss(1,229)(859)
Accumulated deficitAccumulated deficit(379,922)(333,040)Accumulated deficit(409,731)(388,523)
Total stockholders’ equity (deficit)(14,690)31,034 
Total liabilities and stockholders’ equity (deficit)$16,688 $75,503 
Total stockholders’ deficitTotal stockholders’ deficit(32,918)(20,425)
Total liabilities and stockholders’ deficitTotal liabilities and stockholders’ deficit$12,398 $14,436 
See Notes to Unaudited Condensed Consolidated Financial Statements
1

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(dollars in thousands, except per share amounts)
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Revenue, including amounts from China Business Partner (See Note 15)
$2,812 $1,234 $10,037 $9,656 
Cost and expense
Cost of revenue (excluding depreciation and amortization)2,459 854 8,576 5,858 
Sales and marketing270 882 606 2,281 
Technology and development41 635 1,004 3,490 
General and administrative6,726 5,493 14,598 10,672 
Depreciation and amortization43 35 121 150 
Total cost and expense9,539 7,899 24,905 22,451 
Operating loss(6,727)(6,665)(14,868)(12,795)
Other income (expense)
Interest expense(1,365)(438)(5,325)(1,053)
Change in fair value of warrant liability— 411 — 123 
Gain (loss) on investment(348)78,917 (26,356)78,917 
Gain on debt extinguishment— 425 — 425 
Other gain (loss), net(493)96 (342)116 
Total other income (expense), net(2,206)79,411 (32,023)78,528 
Loss before income taxes(8,933)72,746 (46,891)65,733 
Provision for income taxes— (9)
Net income (loss)$(8,924)$72,746 $(46,882)$65,724 
Other comprehensive income
Foreign currency translation adjustments(445)(9)(867)46 
Comprehensive income (loss)$(9,369)$72,737 $(47,749)$65,770 
Weighted-average shares outstanding, basic105,290,553 100,140,650 105,290,553 100,087,288 
Weighted-average shares outstanding, diluted105,290,553 100,379,533 105,290,553 100,409,650 
Net income (loss) per share, basic$(0.08)$0.73 $(0.45)$0.66 
Net income (loss) per share, diluted$(0.08)$0.72 $(0.45)$0.65 
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Revenue, including amounts from China Business Partner (See Note 15)
$183 $2,812 $4,176 $10,037 
Cost and expense
Cost of revenue (excluding depreciation and amortization)254 2,459 3,220 8,576 
Sales and marketing340 270 1,093 606 
Technology and development768 41 1,504 1,004 
General and administrative2,843 6,726 8,920 14,598 
Depreciation and amortization107 43 178 121 
Impairments— — 392 — 
Total cost and expense4,312 9,539 15,307 24,905 
Operating loss(4,129)(6,727)(11,131)(14,868)
Other income (expense)
Interest expense(949)(1,365)(3,351)(5,325)
Finance cost related to obligations to issue common stock(2,086)— (6,712)— 
Loss on investment— (348)— (26,356)
Other gain, net(8)(493)(14)(342)
Total other expense, net(3,043)(2,206)(10,077)(32,023)
Loss before income taxes(7,172)(8,933)(21,208)(46,891)
Provision for income taxes— — 
Net loss$(7,172)$(8,924)$(21,208)$(46,882)
Other comprehensive income
Foreign currency translation adjustments175 (445)(370)(867)
Comprehensive loss$(6,997)$(9,369)$(21,578)$(47,749)
Weighted-average shares outstanding, basic and diluted18,377,384 10,529,055 15,355,583 10,529,055 
Net loss per share, basic and diluted$(0.39)$(0.85)$(1.38)$(4.45)

See Notes to Unaudited Condensed Consolidated Financial Statements
2

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Stockholders’ Equity (Deficit)Deficit
(in thousands, except number of shares)
Three Months Ended September 30, 2022
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at June 30, 2022105,157,769 $105 $365,263 $(692)$(370,998)(6,322)
Net loss— — — — (8,924)(8,924)
Share-based compensation— — 501 — — 501 
Common stock issued for services1,250,000 499 — — 500 
Foreign currency translation— — — (445)— (445)
Balance at September 30, 2022106,407,769 $106 $366,263 $(1,137)$(379,922)$(14,690)
Three Months Ended September 30, 2021
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at June 30, 202199,918,941 $100 $352,394 $(171)$(367,534)$(15,211)
Net income— — — — 72,746 72,746 
Share-based compensation— — 3,798 — — 3,798 
Common stock and stock warrants issued for cash4,237,290 4,610 — — 4,614 
Equity instrument exercises85,000 — 56 — — 56 
Common stock issuance upon note payable conversion876,493 1,104 — — 1,105 
Reclassification of warrant liability to equity— — 1,602 — — 1,602 
Foreign currency translation— — — (9)— (9)
Other(9,000)— — — — — 
Balance at September 30, 2021105,108,724 $105 $363,564 $(180)$(294,788)$68,701 
Nine Months Ended September 30, 2022
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at December 31, 2021105,157,769 $105 $364,239 $(270)$(333,040)$31,034 
Net loss— — — — (46,882)(46,882)
Share-based compensation— — 1,525 — — 1,525 
Common stock issued for services1,250,000 499 — — 500 
Equity instrument exercises— — — — — — 
Foreign currency translation— — — (867)— (867)
Balance at September 30, 2022106,407,769 $106 $366,263 $(1,137)$(379,922)$(14,690)
Nine Months Ended September 30, 2021
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at December 31, 202099,505,041 $100 $351,546 $(226)$(360,512)$(9,092)
Net income— — — — 65,724 65,724 
Share-based compensation— — 3,823 — — 3,823 
Common stock and stock warrants issued for cash4,237,290 4,610 — — 4,614 
Equity instrument exercises498,900 — 879 — — 879 
Common stock issuance upon note payable conversion876,493 1,104 — — 1,105 
Reclassification of warrant liability to equity— — 1,602 — — 1,602 
Foreign currency translation— — — 46 — 46 
Other(9,000)— — — — — 
Balance at September 30, 2021105,108,724 $105 $363,564 $(180)$(294,788)$68,701 
Three Months Ended September 30, 2023
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at June 30, 202316,612,266 $17 $375,517 $(1,404)$(402,559)(28,429)
Net loss— — — — (7,172)(7,172)
Share-based compensation— — 11 — — 11 
Common stock issued pursuant to agreements with Ionic (Note 11)
3,099,589 2,494 — — 2,497 
Foreign currency translation— — — 175 — 175 
Balance at September 30, 202319,711,855 $20 $378,022 $(1,229)$(409,731)$(32,918)
Three Months Ended September 30, 2022
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at June 30, 202210,515,777 $11 $365,357 $(692)$(370,998)$(6,322)
Net loss— — — — (8,924)(8,924)
Share-based compensation— — 501 — — 501 
Common stock issued for services125,000 499 — — 500 
Foreign currency translation— — — (445)— (445)
Balance at September 30, 202210,640,777 $12 $366,357 $(1,137)$(379,922)$(14,690)
Nine Months Ended September 30, 2023
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at December 31, 202211,539,564 $12 $368,945 $(859)$(388,523)$(20,425)
Net loss— — — — (21,208)(21,208)
Share-based compensation— — 167 — — 167 
Common stock issued pursuant to agreements with Ionic (Note 11)
8,172,291 8,910 — — 8,918 
Foreign currency translation— — — (370)— (370)
Balance at September 30, 202319,711,855 $20 $378,022 $(1,229)$(409,731)$(32,918)
Nine Months Ended September 30, 2022
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at December 31, 202110,515,777 $11 $364,333 $(270)$(333,040)$31,034 
Net loss— — — — (46,882)(46,882)
Share-based compensation— — 1,525 — — 1,525 
Common stock issued for services125,000 499 — — 500 
Foreign currency translation— — — (867)— (867)
Balance at September 30, 202210,640,777 $12 $366,357 $(1,137)$(379,922)$(14,690)

See Notes to Unaudited Condensed Consolidated Financial Statements
3

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
Nine Months Ended September 30,Nine Months Ended September 30,
2022202120232022
Cash flows from operating activities:Cash flows from operating activities:Cash flows from operating activities:
Net lossNet loss$(46,882)$65,724 Net loss$(21,208)$(46,882)
Adjustments to reconcile net loss to net cash used in operating activities:Adjustments to reconcile net loss to net cash used in operating activities:Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liability— (123)
Depreciation, amortization and impairments121 150 
Depreciation and amortizationDepreciation and amortization178 121 
Share-based compensationShare-based compensation1,185 3,497 Share-based compensation149 1,185 
Amortization of debt issuance costs and discountAmortization of debt issuance costs and discount2,189 312 Amortization of debt issuance costs and discount— 2,189 
Finance fee283 — 
Cost of extending note payableCost of extending note payable750 — 
Finance cost related to obligations to issue common stockFinance cost related to obligations to issue common stock6,712 — 
Accrued interest included in note payableAccrued interest included in note payable1,139 283 
Stock issuance for services performedStock issuance for services performed500 — Stock issuance for services performed— 500 
Loss on investmentLoss on investment26,356 (78,917)Loss on investment— 26,356 
Gain on debt extinguishment— (425)
Loss on disposal of long-lived assets— 30 
Financing cost of converting note payable to common stock— 44 
Impairment of assetsImpairment of assets392 — 
Provision for doubtful accountsProvision for doubtful accounts2,278 — Provision for doubtful accounts138 2,278 
OtherOther(178)20 Other224 (178)
Changes in operating assets and liabilities:Changes in operating assets and liabilities:Changes in operating assets and liabilities:
Accounts receivableAccounts receivable1,298 (2,182)Accounts receivable(593)1,298 
InventoryInventory(209)(1,062)Inventory83 (209)
Deferred cost of revenueDeferred cost of revenue(5,041)— Deferred cost of revenue1,564 (5,041)
Prepaid expense and other assetsPrepaid expense and other assets3,815 241 Prepaid expense and other assets85 3,815 
Operating lease assetsOperating lease assets63 238 Operating lease assets(503)63 
Accounts payable, accrued expense and other liabilitiesAccounts payable, accrued expense and other liabilities826 2,047 Accounts payable, accrued expense and other liabilities1,437 826 
Contract liabilityContract liability(245)435 Contract liability90 (245)
Operating lease liabilitiesOperating lease liabilities(146)Operating lease liabilities280 
Net cash used in operating activitiesNet cash used in operating activities(13,635)(10,117)Net cash used in operating activities(9,083)(13,635)
Cash flows from investing activities:Cash flows from investing activities:Cash flows from investing activities:
Proceeds from sale of investmentProceeds from sale of investment6,332 2,322 Proceeds from sale of investment— 6,332 
Purchases of property, equipment and softwarePurchases of property, equipment and software(175)(155)Purchases of property, equipment and software(32)(175)
Payment of amounts capitalized to software in progressPayment of amounts capitalized to software in progress(999)— Payment of amounts capitalized to software in progress— (999)
Net cash provided by (used in) investing activitiesNet cash provided by (used in) investing activities5,158 2,167 Net cash provided by (used in) investing activities(32)5,158 
Cash flows from financing activities:Cash flows from financing activities:Cash flows from financing activities:
Proceeds from issuance of common stock, netProceeds from issuance of common stock, net— 5,494 Proceeds from issuance of common stock, net— — 
Proceeds from debt issuance— 4,770 
Proceeds from obligations to issue common stock - ELOCProceeds from obligations to issue common stock - ELOC7,000 — 
Proceeds from obligations to issue common stock - DebenturesProceeds from obligations to issue common stock - Debentures2,500 — 
Advances from related partiesAdvances from related parties2,386 — Advances from related parties1,002 2,386 
Repayments of advances from related partiesRepayments of advances from related parties(1,517)— Repayments of advances from related parties(1,145)(1,517)
Repayments of debtRepayments of debt(6,203)— Repayments of debt(24)(6,203)
Net cash provided by (used in) financing activitiesNet cash provided by (used in) financing activities(5,334)10,264 Net cash provided by (used in) financing activities9,333 (5,334)
Net change in cashNet change in cash(13,811)2,314 Net change in cash218 (13,811)
Cash:Cash:Cash:
Beginning of periodBeginning of period14,187 854 Beginning of period52 14,187 
End of periodEnd of period$376 $3,168 End of period$270 $376 
Supplemental cash flow information:Supplemental cash flow information:Supplemental cash flow information:
Cash paid for interestCash paid for interest$3,238 $— Cash paid for interest$1,578 $3,238 
Supplemental schedule of non-cash investing and financing activities:Supplemental schedule of non-cash investing and financing activities:Supplemental schedule of non-cash investing and financing activities:
Transfer of marketable securities to partially settle notes payableTransfer of marketable securities to partially settle notes payable$9,661 $— Transfer of marketable securities to partially settle notes payable$— $9,661 
Finance feeFinance fee$283 $— Finance fee$— $283 
Issuance of common stock upon note payable conversion$— $1,105 
Reclassification of warrant liability to equity$— $1,602 
Reclassification of investment to marketable securities$— $1,030 
Issuance of common stock pursuant to equity line of creditIssuance of common stock pursuant to equity line of credit$8,910 $— 
Transfer of software to inventoryTransfer of software to inventory$233 $— 
Change in liability for China Cash Bonuses (Note 12)
$340 $326 

See Notes to Unaudited Condensed Consolidated Financial Statements
4

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements
For the Nine Months Ended September 30, 20222023 and 20212022

NOTE 1. ORGANIZATION AND BUSINESS

Organization and Business

Remark Holdings, Inc. and its subsidiaries (“Remark”, “we”, “us”, or “our”) constitute a diversified global technology business with leading artificial intelligence (“AI”) and data-analytics solutions. The common stock of Remark Holdings, Inc. is listed on the Nasdaq Capital Market (“Nasdaq”) under the tickertrading symbol MARK.

We primarily sell AI-based products and services. We currently recognize substantially all of our revenue from China, with additional revenue from sales in the U.S.

On December 21, 2022, we effected a 1-for-10 reverse split of our common stock (the “Reverse Split”). All references made to share or per share amounts in these financial statements have been retroactively adjusted to reflect the effects of the Reverse Split.


Corporate Structure

We are a holding company incorporated in Delaware and not a Chinese operating company. As a holding company, we conduct most of our operations through our subsidiaries, each of which is wholly owned. We haveUntil September 2022, we had historically conducted a significant part of our operations through contractual arrangements between our wholly-foreign-owned enterprise (“WFOE”) and certain variable interest entities (“VIEs”) based in China to address challenges resulting from laws, policies and practices that may disfavor foreign-owned entities that operate within industries deemed sensitive by the Chinese government. We were the primary beneficiary of the VIEs because the contractual arrangements governing the relationship between the VIEs and our WFOE, which included an exclusive call option agreement, exclusive business cooperation agreement, a proxy agreement and an equity pledge agreement, enabled us to (i) exercise effective control over the VIEs, (ii) receive substantially all of the economic benefits of the VIEs, and (iii) have an exclusive call option to purchase, at any time, all or part of the equity interests in and/or assets of the VIEs to the extent permitted by Chinese laws. Because we were the primary beneficiary of the VIEs, we consolidated the financial results of the VIEs in our consolidated financial statements in accordance with generally accepted accounting principles (“GAAP”).

We terminated all of the contractual arrangements between the WFOE and the VIEs and exercised our rights under the exclusive call option agreements between the WFOE and the VIEs such that, effective as of September 19, 2022, we obtained 100% of the equity ownership of the entities we formerly consolidated as VIEs and which we now consolidate as wholly-owned subsidiaries.

The following diagram illustrates our corporate structure, including our significant subsidiaries, as of the date of this Form 10-Q. The diagram omits certain entities which are immaterial to our results of operations and financial condition.


5


Remark Org Chart - Oct 2022 No VIE.jpg


We are subject to certain legal and operational risks associated with having a significant portion of our operations in China. Chinese laws and regulations governing our current business operations, including the enforcement of such laws and regulations, are sometimes vague and uncertain and can change quickly with little advance notice. The Chinese government may intervene in or influence the operations of our China-based subsidiaries at any time and may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in our operations and/or the value of our securities. In addition, any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors and cause the value of such securities to
6


significantly decline or become worthless. In recent years, the Chinese government adopted a series of regulatory actions and issued statements to regulate business operations in China, including those related to the use of variable interest entities, cybersecurity, data security, export control and anti-monopoly concerns. As of the date of this Form 10-Q, we have neither been involved in any investigations on cybersecurity review initiated by any Chinese regulatory authority, nor received any inquiry, notice or sanction. As of the date of this Form 10-Q, no relevant laws or regulations in China explicitly require us to seek approval from the China Securities Regulatory Commission (“CSRC”) for any securities listing. As of the date of this Form 10-Q, we have not received any inquiry, notice, warning or sanctions regarding our planned overseas listing from the CSRC or any other Chinese governmental authorities relating to securities listings. However, since these statements and regulatory actions are newly published, official guidance and related implementation rules have not all been issued. It is highly uncertain what potential impact such modified or new laws and regulations will have on our ability to conduct our business, accept investments or list or maintain a listing on a U.S. or foreign exchange.

As of the date of this Form 10-Q, we are not required to seek permissions from the CSRC, the Cyberspace Administration of China (the “CAC”), or any other entity that is required to approve our operations in China. Nevertheless, Chinese regulatory authorities may in the future promulgate laws, regulations or implement rules that require us or our subsidiaries to obtain permissions from such regulatory authorities to approve our operations or any securities listing.


Holding Foreign Companies Accountable Act

The Holding Foreign Companies Accountable Act (the “HFCA Act”) was enacted on December 18, 2020. The HFCA Act states that if the Securities and Exchange Commission (the “SEC”) determines that a company has filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the Public Company Accounting Oversight Board (the “PCAOB”) for three consecutive years beginning in 2021, the SEC shall prohibit such shares from being traded on a national securities exchange or in the over the counter trading market in the United States. On June 22, 2021, the U.S. Senate passed a bill which, if passed by the U.S. House of Representatives and signed into law, would reduce the number of consecutive non-inspection years required for triggering the prohibitions under the HFCA Act from three years to two. On December 2, 2021, the SEC adopted amendments to finalize rules implementing the submission and disclosure requirements in the HFCA Act. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB is unable to inspect or investigate completely because of a position taken by an authority in a foreign jurisdiction. The Consolidated Appropriations Act, 2023, which was signed into law on December 29, 2022, amended the HFCA Act to reduce the number of consecutive non-inspection years required to trigger the trading prohibition under the HFCA Act from three years to two years.

On December 16, 2021, the PCAOB issued a report on its determination that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in mainland China and in Hong Kong because of positions taken by Chinese and Hong Kong authorities in those jurisdictions. The PCAOB has made such determination as mandated under the HFCA Act. Pursuant to each annual determination by the PCAOB, the SEC will, on an annual basis, identify issuers that have used non-inspected audit firms and thus are at risk of such suspensions in the future.

On August 26, 2022, the CSRC, the Ministry of Finance of the PRC, and the PCAOB signed a Statement of Protocol (the “Protocol”), taking the first step toward opening access for the PCAOB to completely inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong. Pursuant to the Protocol,

On December 15, 2022, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigationvacated its 2021 determination that the positions taken by authorities in mainland China and has the unfettered ability to transfer information to the SEC. However, uncertainties still exist as to compliance with the Protocol. Depending on the implementationHong Kong prevented it from inspecting and investigating completely registered public accounting firms headquartered in those jurisdictions. In view of the Protocol, ifPCAOB’s decision to vacate its 2021 determination and until such time as the PCAOB continuesissues any new adverse determination, the SEC has stated that there are no issuers at risk of having their securities subject to be prohibited from conductinga trading prohibition under the HFCA Act. Each year, the PCAOB will reassess its determinations on whether it can inspect and investigate completely audit firms in China, and if, in the future, the PCAOB determines it cannot do so, or if Chinese authorities do not allow the PCAOB complete access for inspections and investigations of PCAOB-registeredfor two consecutive years, companies engaging China-based public accounting firms in China, then China-based companies willwould be delisted pursuant to the HFCA Act despite the Protocol. Therefore, there is no assurance that the Protocol could give relief to China-based companies against the delisting risk from the application of the HFCA Act.

Our auditor, Weinberg & Company, an independent registered public accounting firm headquartered in the United States is not subject to the determinations announced by the PCAOB on December 16, 2021. Our auditor is currently subject to PCAOB inspections and has been inspected by the PCAOB on a regular basis. However, if the PCAOB is unable to inspect the work papers of our accounting firm in the future, such lack of inspection could cause trading in our common stock to be prohibited under the HFCA Act, and as a result, an exchange may determine to delist our common stock. The delisting and the cessation of trading of our common stock, or the threat of our common stock being delisted and prohibited from being traded, may materially and adversely affect the value of your investment.our common stock.


7


Transfer of Cash or Assets

Dividend Distributions

As of the date of this Form 10-Q, none of our subsidiaries have made any dividends or distributions to Remark.

We have never declared or paid dividends or distributions on our common equity. We currently intend to retain all available funds and any future consolidated earnings to fund our operations and continue the development and growth of our business; therefore, we do not anticipate paying any cash dividends.

Under Delaware law, a Delaware corporation’s ability to pay cash dividends on its capital stock requires the corporation to have either net profits or positive net assets (total assets less total liabilities) over its capital. If we determine to pay dividends on any of our common stock in the future, as a holding company, we may rely on dividends and other distributions on equity from our subsidiaries for cash requirements, including the funds necessary to pay dividends and other cash contributions to our stockholders.

Our WFOE’s ability to distribute dividends is based upon its distributable earnings. Current Chinese regulations permit our WFOE to pay dividends to its shareholder only out of its registered capital amount, if any, as determined in accordance with Chinese accounting standards and regulations, and then only after meeting the requirement regarding statutory reserve. If our WFOE incurs debt in the future, the instruments governing the debt may restrict its ability to pay dividends or make other payments to us. Any limitation on the ability of our WFOE to distribute dividends or other payments to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our businesses, pay dividends or otherwise fund and conduct our business. In addition, any cash dividends or distributions of assets by our WFOE to its stockholder are subject to a Chinese withholding tax of as much as 10%.

The Chinese government also imposes controls on the conversion of Chinese Renminbi (“RMB”) into foreign currencies and the remittance of currencies out of China. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from our profits, if any. If we are unable to receive all of the revenues from our operations through our China-based subsidiaries, we may be unable to pay dividends on our common stock.


COVID-19

Our condensed consolidated financial statements for the nine months ended September 30, 2022 were impacted by2023 continued to show the effects of the COVID-19 pandemic. The response tonegative impact that the COVID-19 pandemic will likelyhas had on our business. Preventative measures related to COVID-19 outbreaks may continue to adversely affect our business and financial results, as could economic and geopolitical conditions in some international regions, and we do not yet know what will be the ultimate effects on our business. The COVID-19 pandemic caused a broad shift towards remote working arrangements for many businesses worldwide and injected uncertainty and delay into decision-making processes for such businesses. Varying degrees ofThough the most restrictive preventative measures are stillhave been eased in place in China, and other parts of the world, including city-wide lockdowns, travel restrictions, closures of non-essential businesses and other quarantine measures. In particular,measures could be reinstituted at any time. Recovering from the effects of the preventative measures in China as a result ofthat resulted from the Chinese government’s “Zero-COVID”Zero-COVID policy haveand that significantly limited the operational capabilities of our China-based subsidiaries. Manysubsidiaries has been a slow process. Though the weeks-long or months-long lockdowns instituted in many cities across large swaths of China, have recently been fully or partially locked down for weeks or even months, including economically significant regions such as Shanghai. Such lockdownsShanghai, were lifted as of the end of 2022, they have had a material adverse impact on our business, including on the collection of our accounts receivable and we expect themour ability to complete projects in China to generate revenue, and may continue to have a material adverseadversely impact on our business until customers and potential customers believe they can operate and expand their imposition is ceased.businesses without fear of lockdowns or other severely restrictive preventative measures.

The full extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including resurgences and further spread of existing or new COVID-19 variants, the duration of any remaining preventative measures implemented by domestic and foreign governments, the impact on capital and financial markets and the related impact on the financial circumstances of our customers, all of which are highly uncertain and cannot be predicted. The pandemic-relatedCOVID-19 situation continues to changehas historically changed rapidly, and additional impacts of which we are not currently aware may arise. We are closely monitoring worldwide developments and are continually assessingassess the potential impact on our business.

 
8


Going Concern
 
During the nine months ended September 30, 2022,2023, and in each fiscal year since our inception, we have incurred operating losses which have resulted in a stockholders’ deficit of $14.7$32.9 million as of September 30, 2022.2023. Additionally, our operations have historically used more cash than they have provided. Subsequent to September 30, 2022, we did not make the required repayment of the outstanding loans under the Mudrick Loan Agreements by October 31, 2022, the maturity date. This constitutes an event of default for which we have not received a waiver as of the date of this Form 10-Q. Net cash used in operating activities was $13.6$9.1 million during the nine months ended September 30, 2022.2023. As of September 30, 2022,2023, our cash balance was $0.4$0.3 million. Also, we did not make required repayments of the outstanding loans under the New Mudrick Loan Agreement when due (see Note 10 for more information).

Our history of recurring operating losses, working capital deficiencies and negative cash flows from operating activities give rise to, and management has concluded that there is, substantial doubt regarding our ability to continue as a going concern. Our independent registered public accounting firm, in its report on our consolidated financial statements for the year ended December 31, 2021,2022, has also expressed substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

We intend to fund our future operations and meet our financial obligations through revenue growth from our AI and data analytics offerings. We cannot, however, provide assurance that revenue, income and cash flows generated from our businesses will be sufficient to sustain our operations in the twelve months following the filing of this Form 10-Q. As a result, we are actively evaluating strategic alternatives including debt and equity financings.

Conditions in the debt and equity markets, as well as the volatility of investor sentiment regarding macroeconomic and microeconomic conditions (in particular, as a result of the COVID-19 pandemic, global supply chain disruptions, inflation and other cost increases, and the geopolitical conflict in Ukraine), will play primary roles in determining whether we can successfully obtain additional capital. We cannot be certain that we will be successful at raising additional capital.

A variety of factors, many of which are outside of our control, affect our cash flow; those factors include the effects of the COVID-19 pandemic, regulatory issues, competition, financial markets and other general business conditions. Based on financial projections, we believe that we will be able to meet our ongoing requirements for at least the next 12 months with existing cash and based on the probable success of one or more of the following plans:

develop and grow new product line(s)

obtain additional capital through debt and/or equity issuances.

However, projections are inherently uncertain and the success of our plans is largely outside of our control. As a result, there is substantial doubt regarding our ability to continue as a going concern, and we may fully utilize our cash resources prior to December 31, 2022.2023.


NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

We prepared the accompanying unaudited Condensed Consolidated Balance Sheet as of September 30, 2022,2023, with the audited Consolidated Balance Sheet amounts as of December 31, 20212022 presented for comparative purposes, and the related unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, the Condensed Consolidated Statements of Cash Flows and the Condensed Consolidated Statements of Stockholders’ Deficit nine months ended September 30, 2023 in accordance with the instructions for Form 10-Q. In compliance with those instructions, we have omitted certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP, though management believes the disclosures made herein are sufficient to ensure that the information presented is not misleading.

Our results of operations and our cash flows as of the end of the interim periods reported herein do not necessarily indicate the results we may experience for the remainder of the year or for any other future period.

Management believes that we have included all adjustments (including those of a normal, recurring nature) considered necessary to fairly present our unaudited Condensed Consolidated Balance Sheet and our unaudited Condensed Consolidated
9


Statement of Stockholders’ Deficit, each as of September 30, 2022,2023, as well as our unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Condensed Consolidated Statements of Cash Flows for all periods presented. You should read our unaudited condensed consolidated interim financial statements and footnotes in conjunction with our consolidated financial statements and footnotes included within the Annual Report on Form 10-K for the year ended December 31, 20212022 (the “2021“2022 Form 10-K”).


Consolidation

We include all of our subsidiaries in our condensed consolidated financial statements, eliminating all significant intercompany balances and transactions during consolidation.
 

Use of Estimates
 
We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, deferred cost of revenue, share-based compensation, deferred income taxes, and inventory reserve, among other items.

The impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods.


Cash

Our cash consists of funds held in bank accounts.

We maintain cash balances in United States dollars (“USD”), British pounds (“GBP”), RMB and Hong Kong dollars (“HKD”). The following table, reported in USD, disaggregates our cash balances by currency denomination (in thousands):
September 30, 2022December 31, 2021September 30, 2023December 31, 2022
Cash denominated in:Cash denominated in:Cash denominated in:
USDUSD$$13,278 USD$250 $11 
RMBRMB199 259 RMB13 19 
GBPGBP166 644 GBP17 
HKDHKDHKD
Total cashTotal cash$376 $14,187 Total cash$270 $52 


We maintain substantially all of our USD-denominated cash at a U.S. financial institution where the balances are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At times, however, our cash balances may exceed the FDIC-insured limit. As of September 30, 2022,2023, we do not believe we have any significant concentrations of credit risk. Cash held by our non-U.S. subsidiaries is subject to foreign currency fluctuations against the USD, although such risk is somewhat mitigated because we transfer U.S. funds to China to fund local operations. If, however, the USD is devalued significantly against the RMB, our cost to further develop our business in China could exceed original estimates.
10




Marketable Securities

Investment in marketable securities consists of marketable equity securities. We classify marketable securities as current or noncurrent based on the nature of the securities and their availability for use in current operations. Marketable securities are stated at fair value with all realized and unrealized gains and losses recognized in our Statement of Operations. The realized and unrealized gains and losses on marketable securities are determined using the specific identification method and quoted prices in an active market.


Fair Value of Financial Instruments

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants (an exit price). When reporting the fair values of our financial instruments, we prioritize those fair value measurements into one of three levels based on the nature of the inputs, as follows:

Level 1:    Valuations based on quoted prices in active markets for identical assets and liabilities;

Level 2:    Valuations based on observable inputs that do not meet the criteria for Level 1, including quoted prices in inactive markets and observable market data for similar, but not identical instruments; and

Level 3:    Valuations based on unobservable inputs, which are based upon the best available information when external market data is limited or unavailable.

The fair value hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not be available.

We believe the reported carrying amounts for cash, marketable securities, receivables, prepaids and other current assets, accounts payable, accrued expense and other current liabilities, and short-term debt approximate their fair values because of the short-term nature of these financial instruments.


Foreign Currency Translation

We report all currency amounts in USD. Our overseas subsidiaries, however, maintain their books and records in their functional currencies, which are GBP in the United Kingdom (“U.K.”) and RMB in China.

In general, when consolidating our subsidiaries with non-USD functional currencies, we translate the amounts of assets and liabilities into USD using the exchange rate on the balance sheet date, and the amounts of revenue and expense are translated at the average exchange rate prevailing during the period. The gains and losses resulting from translation of financial statement amounts into USD are recorded as a separate component of accumulated other comprehensive loss within stockholders’ deficit.

We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted:
20232022
Exchange rates at September 30th:
GBP:USD1.220 1.113 
RMB:USD0.137 0.141 
HKD:USD0.128 0.127 
Average exchange rate during the nine months ended September 30th:
RMB:USD0.142 0.152 
GBP:USD1.244 1.259 


11


We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted:
20222021
Exchange rates at September 30th:
GBP:USD1.113 — 
RMB:USD0.141 0.155 
HKD:USD0.127 0.129 
Average exchange rate during the nine months ended September 30th:
RMB:USD0.152 0.156 
GBP:USD1.259 — 


Revenue Recognition

AI-Based Products

We generate revenue by developing AI-based products, including fully-integrated AI solutions which combine our proprietary technology with third-party hardware and software products to meet end-user specifications. Under one type of contract for our AI-based products, we provide a single, continuous service to clients who control the assets as we create them. Accordingly, we recognize the revenue over the period of time during which we provide the service. Under another type of contract, we have performance obligations to provide fully-integrated AI solutions to our customer and we recognize revenue at the point in time when each performance obligation is completed and delivered to, tested by and accepted by our customer.

We recognize revenue when we transfer control of the promised goods or services to our customers, and we recognize an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. If there is uncertainty related to the timing of collections from our customer, which may be the case if our customer is not the ultimate end user of our goods, we consider this to be uncertainty of the customer’s ability and intention to pay us when consideration is due. Accordingly, we recognize revenue only when we have transferred control of the goods or services and collectability of consideration from the customer is probable.

When customers pay us prior to when we satisfy our obligation to transfer control of promised goods or services, we record the amount that reflects the consideration to which we expect to be entitled as a contract liability until such time as we satisfy our performance obligation.

For contracts under which we have not yet completed the performance obligation, deferred costs are recorded for any amounts incurred in advance of the performance obligation.

For our contracts with customers, we generally extend short-term credit policies to our customers, typically up to one year for large-scale projects.

We record the incremental costs of obtaining contracts as an expense when incurred.

We offer extended warranties on our products for periods of one to three years. Revenue from these extended warranties is recognized on a straight-line basis over the warranty contract term.


Other

We generate revenue from other sources, such as from advertising and marketing services or e-commerce activity in which we sell goods to our customers.services. We recognize the revenue from these contracts at the point in time when we transfer control of
12


the good sold to the customer or when we deliver the promised promotional materials or media content. Substantially all of our contracts with customers that generate Other revenue are completed within one year or less.


12


Inventory

We use the first-in first-out method to determine the cost of our inventory, then we report inventory at the lower of cost or net realizable value. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated sales forecasts. At September 30, 20222023 and December 31, 2021,2022, reserve for inventory was $0.9$2.2 million and $1.0$2.2 million, respectively.


Refundable Tax Credits

We charge the cost of our research and development efforts to operations as incurred. Our subsidiary in the United Kingdom is entitled to receive certain government assistance in the form of refundable research and development tax credits from taxation authorities, based on qualifying expenditures incurred during the fiscal year. The refundable credits are not dependent on our ongoing tax status or tax position and accordingly are not considered part of income taxes. We record refundable tax credits as a reduction of technology and development expense when we can reasonably estimate the amount and it is more likely than not that such amount will be received. During the nine months ended September 30, 2023, we recorded a tax credit of approximately $0.5 million.


Internal Use Software

We acquire or develop applications and other software that help us meet our internal needs with respect to operating our business. For such projects, planning cost and other costs related to the preliminary project stage, as well as costs incurred for post-implementation activities, are expensed as incurred. We capitalize costs incurred during the application development phase only when we believe it is probable the development will result in new or additional functionality. The types of costs capitalized during the application development phase include fees incurred with third parties for consulting, programming and other development activities performed to complete the software. We amortize our internal use software on a straight-line basis over an estimated useful life of three years. If we identify any internal use software to be abandoned, the cost less the accumulated amortization, if any, is recorded as amortization expense. Once we have fully amortized internal use software costs that we capitalized, we remove such amounts from their respective accounts.


Net Income (Loss) per Share

We calculate basic net income (loss) per share using the weighted-average number of common stock shares outstanding during the period. For the calculation of diluted net income (loss) per share, we give effect to all the shares of common stock that were outstanding during the period plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is anti-dilutive. Dilutive potential shares of common stock consist of incremental shares of common stock issuable upon exercise of stock options and warrants.

For the three and nine months ended September 30, 20222023 and 2021,2022, there were no reconciling items related to either the numerators of the net income (loss) per share calculations. The following table presents a reconciliation of thenumerator or denominator of the basic net income (loss)loss per share calculation, to that of the diluted net income (loss) per share calculation (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Weighted-average shares outstanding, basic105,290,553 100,140,650 105,290,553 100,087,288 
Incremental shares resulting from assumed exercises of in-the-money stock options— 238,883 — 322,362 
Weighted-average shares outstanding, diluted105,290,553 100,379,533 105,290,553 100,409,650 
as their effect would have been anti-dilutive.

Securities which may have affected the calculation of diluted earnings per share for the three and nine months ended September 30, 20222023 if their effect had been dilutive include 15,123,7521,623,346 total outstanding options to purchase our common stock, options and 10,114,4081,011,441 outstanding warrants to purchase our common stock.stock, as well as an estimated 18,420,287 shares of our common stock issuable to Ionic Ventures, LLC (“Ionic”) in relation to our transactions with Ionic (see Note 11).


13


Segments

Existing GAAP, which establishes a management approach to segment reporting, defines operating segments as components of an entity about which separate, discrete financial information is available for evaluation by the chief operating decision maker. We have identified our Chief Executive Officer as our chief operating decision maker, who reviews operating results to make decisions about allocating resources and assessing performance based upon only one operating segment.

13



Recently Issued Accounting Pronouncements

In June 2016,August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-132020-06 (“ASU 2016-13”2020-06”), Measurement of Credit Losses on FinancialDebt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments (Topic 326)and Contracts in an Entity’s Own Equity. The ASU requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain typeswill simplify the accounting for convertible instruments by reducing the number of financialaccounting models for convertible debt instruments including trade receivables, which mayand convertible preferred stock. Limiting the accounting models will result in fewer embedded conversion features being separately recognized from the earlier recognitionhost contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of allowancesa derivative, and that do not qualify for losses.a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The ASU also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. With regard to our financial reporting, ASU 2016-132020-06 will be effective beginning January 1, 2023,2024, and early adoption is permitted.permitted, but no earlier than January 1, 2021, including interim periods within that year. We are currently evaluating what effect(s) the adoption of ASU 2020-06 may have on our consolidated financial statements, but we do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption.

We have reviewed all accounting pronouncements recently issued by the FASB and the SEC. The authoritative pronouncements that we have already adopted did not have a material effect on our financial condition, results of operations, cash flows or reporting thereof, and except as otherwise noted above, we do not believe that any of the authoritative pronouncements that we have not yet adopted will have a material effect upon our financial condition, results of operations, cash flows or reporting thereof.


NOTE 3. CONCENTRATION OF RISK

Revenue and Accounts Receivable

The disaggregation of revenue tables in Note 4 demonstrate the concentration in our revenue from certain products and the geographic concentration of our business. We also have a concentration in the volume of business we transacted with customers, as during the nine months ended September 30, 2022,2023, two of our customers represented about 28% and 24% of our revenue, respectively, while during nine months ended September 30, 2022, two customers represented about 55% and 23%, respectively, of our revenue, while during nine months ended September 30, 2021, our two largest customers represented about 32% and 21%, respectively, of our revenue. At September 30, 2022,2023, accounts receivable from two of our customers represented about 32% and 18%12% an 12%, respectively, of our gross accounts receivable, while at December 31, 2021,2022, accounts receivable from our three largest customers represented about 25%23%, 24%16% and 10%, respectively, of our gross accounts receivable.


Deferred Cost of Revenue

See Note 6 for a discussion of a risk concentration regarding our deferred cost of revenue.


Cost of Sales and Accounts Payable

The various hardware we purchase to fulfill our contracts with customers is not especially unique in nature. Based on our analysis, we believe that should any disruption in our current supply chain occur, a sufficient number of alternative vendors is available to us, at reasonably comparable specifications and price, such that we would not experience a material negative impact on our ability to procure the hardware we need to operate our business.


NOTE 4. REVENUE

We primarily sell AI-based products and services based upon computer vision and other technologies.

14


We do not include disclosures related to remaining performance obligations because substantially all our contracts with customers have an original expected duration of one year or less or, with regard to our stand-ready obligations, the amounts involved are not material.


14


Disaggregation of Revenue

The following table presents a disaggregation of our revenue by category of products and services (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,
20222021202220212023202220232022
AI-based products and services, including amounts from China Business Partner in 2022 (See Note 15)
$2,681 $834 $9,699 $8,706 
AI-based products and services, including amounts from China Business Partner in 2023 (See Note 15)
AI-based products and services, including amounts from China Business Partner in 2023 (See Note 15)
$174 $2,681 $4,000 $9,699 
OtherOther131 400 338 950 Other131 176 338 
RevenueRevenue$2,812 $1,234 $10,037 $9,656 Revenue$183 $2,812 $4,176 $10,037 


The following table presents a disaggregation of our revenue by country (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,
20222021202220212023202220232022
ChinaChina$2,746 $840 $9,815 $6,053 China$174 $2,746 $4,014 $9,815 
United States66 394 222 3,603 
United States and United KingdomUnited States and United Kingdom66 162 222 
RevenueRevenue$2,812 $1,234 $10,037 $9,656 Revenue$183 $2,812 $4,176 $10,037 


Significant Judgments

When accounting for revenue we make certain judgments, such as whether we act as a principal or as an agent in transactions or whether our contracts with customers fall within the scope of current GAAP regarding revenue, that affect the determination of the amount and timing of our revenue from contracts with customers. Based on the current facts and circumstances related to our contracts with customers, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted in terms of their potential impact on the amount and timing of our revenue.


Contract Assets and Contract Liabilities

We do not currently generate material contract assets. During the nine months ended September 30, 2022,2023, our contract liability changed only as a result of routine business activity.

During the nine months ended September 30, 20222023 and 2021,2022, the amount of revenue we recognized that was included in the beginning balance of Contract liability was not material.

During the nine months ended September 30, 20222023 and 2021,2022, we did not recognize revenue from performance obligations that were satisfied in previous periods.


Certain Agreements Related to AI-Based Product Sales in China

We completed certain projects in China during the three months ended September 30, 2023 worth approximately $1.4 million, but the agreement has not yet met the criteria for revenue recognition.
15




NOTE 5. TRADE ACCOUNTS RECEIVABLE
September 30, 2022December 31, 2021September 30, 2023December 31, 2022
Gross accounts receivable balanceGross accounts receivable balance$9,184 $11,551 Gross accounts receivable balance$7,103 $7,213 
Allowance for bad debtAllowance for bad debt(3,431)(1,284)Allowance for bad debt(4,060)(4,122)
Accounts receivable, netAccounts receivable, net$5,753 $10,267 Accounts receivable, net$3,043 $3,091 


15


Generally, it is not unusual for Chinese entities to pay their vendors on longer timelines than the timelines typically observed in U.S. commerce. However, as a result of the ongoing lockdowns related to China’s Zero-COVID policy, we have had to re-evaluate the amounts receivable from customers based on recent information and, as a result, we increased our reserve for doubtful accounts by $2.3 million.TradeTrade receivables related to our China-based subsidiariesChina AI projects at September 30, 2023 and December 31, 2022; including $3.0approximately $0.6 million and $1.1 million, respectively, of trade receivables from projects related to work with our China Business Partner (see Note 15 for more information regarding our China Business Partner and related accounting), represent 99% of; represented essentially all our gross trade receivables.receivables in each such period. Despite the longer collection timelines normally observed with Chinese entities, we have noted that the COVID-19 related lockdowns that persisted in China for most of 2022 have caused further delay in our ability to collect all balances due from some of our customers in China. As a result of our inability to assure collection of all amounts due from such customers within a short period of time, we recorded a reserve for bad debt of approximately $2.8 million as of December 31, 2022 for all accounts receivable from China customers that were more than one year past due. The additional reserve for bad debt we recorded during 2023 was not material.


NOTE 6. INVESTMENTDEFERRED COST OF REVENUE

In 2009, we co-founded a U.S.-based venture, Sharecare, Inc. (“Legacy Sharecare”), to build a web-based platform that simplifies the search for healthDeferred cost of revenue as of September 30, 2023 and wellness information. The other co-founders of Legacy Sharecare were Dr. Mehmet Oz, HARPO Productions, Discovery Communications, Jeff Arnold and Sony Pictures Television. At December 31, 2021,2022 of $5.9 million and $7.5 million, respectively, represent amounts we reportedhave paid in advance to vendors who provide services to us in relation to various projects in China. Specifically, the deferred cost of revenue balance as of September 30, 2023, a large percentage of which was related to project installations we expected would be provided to us through our $1.0 million investmentChina Business Partner (described in Legacy Sharecaremore detail in Note 15), was paid almost entirely to a single vendor which will be visiting numerous sites across various regions of China to install our software solutions and/or hardware for our customers and perform other services for us pursuant to our customers’ requirements. Because most of the projects for which we have engaged the vendor require purchases of hardware, equipment and/or supplies in advance of site visits, we made the prepayments during 2022 in anticipation of several large batches of project installations. However, the lengthy COVID-19 related lockdowns that occurred in various regions in China prevented us and the vendor from being able to complete as an investmentmany projects as we originally expected and caused our customers to delay installations. Given that the delays were related to the COVID-19 lockdowns that had ended by December 31, 2022 and were not a result of the vendor’s inability to either perform the services or refund of the amounts we advanced, we believe the balance as of September 30, 2023 will be fully recovered. We did not make any additional payments in unconsolidated affiliate.2023 to the vendor assisting us with installations related to projects provided to us through our China Business Partner, and we were able to complete installations that reduced the deferred cost of revenue balance associated with that vendor which caused the net decrease in deferred cost of revenue.

On July 1, 2021, Legacy SharecareWe completed a business combination with Falcon Capital Acquisition Corp., a special purpose acquisition company, as a result of which the common stock of the surviving entity of such business combination (“New Sharecare”) became listed on the Nasdaq Stock Market LLC. In connection with the completion of such business combination, the shares of common stock of Legacy Sharecare that we held immediately prior to the business combination converted into approximately $2.3 millioncertain projects in cash and approximately 9.4 million shares of common stock of New Sharecare. We do not maintain a seat on the board of directors of New Sharecare. The cash received was recorded as a realized gain on the investment, and the investment is revalued at fair value at the end of each reporting period using the closing sales price of the shares on the principal securities exchange on which such shares are then traded.

As of December 31, 2021, the value of our 9,431,920 shares of common stock of New Sharecare was $42.3 million based upon the closing stock price of New Sharecare, an input we classify in Level 1 of the fair value hierarchy. We sold 3,181,920 shares of New SharecareChina during the ninethree months ended September 30, 20222023 worth approximately $1.4 million, but for cashwhich the agreement between us and the customer has not yet met the criteria for revenue recognition. If such agreement had qualified for revenue recognition, $1.2 million of $6.3 million.

On July 2, 2022, we received a Noticecost of Trigger Event and Mandatory Payment from our senior lenders, which required that we make a prepaymentsales would have been recognized, further reducing the balance of our senior secured loans (which are described in Note 11) by delivering to each lender sharesdeferred cost of common stock of New Sharecare in the fair market amount applicable to each such lender to prepay our senior secured loans. On July 11, 2022, we delivered our remaining 6,250,000 shares of New Sharecare, which reduced the outstanding principal amount on our senior secured loans by approximately $9.7 million, and as a result, we no longer own any equity interests in New Sharecare as of such date.

The total net loss on investment during the nine months ended September 30, 2022 was $26.4 million.revenue.


16


NOTE 7. PREPAID EXPENSE AND OTHER CURRENT ASSETS

The following table presents the components of prepaid expense and other current assets (in thousands):
September 30, 2022December 31, 2021September 30, 2023December 31, 2022
Receivable from China Business Partner (See Note 15)
$— $3,980 
Other receivablesOther receivablesOther receivables23 
Prepaid expensePrepaid expense1,285 1,558 Prepaid expense547 1,144 
DepositsDeposits252 221 Deposits245 201 
Other current assetsOther current assetsOther current assets
TotalTotal$1,550 $5,774 Total$801 $1,374 

During the nine months ended September 30, 2023, we recorded an impairment of approximately $0.2 million related to certain prepaid expense amounts which were deemed unrecoverable.


16


NOTE 8. PROPERTY AND EQUIPMENT
Property and equipment consist of the following (in thousands, except estimated lives):
Estimated Life
(Years)
September 30, 2022December 31, 2021Estimated Life
(Years)
September 30, 2023December 31, 2022
VehiclesVehicles3$153 — Vehicles3$153 153 
Computers and equipmentComputers and equipment31,132 $1,133 Computers and equipment31,193 $1,170 
Furniture and fixturesFurniture and fixtures342 42 Furniture and fixtures342 42 
SoftwareSoftware34,886 5,055 Software35,819 5,160 
Leasehold improvementsLeasehold improvements3203 196 Leasehold improvements3206 204 
Software development in progressSoftware development in progress1,136 128 Software development in progress— 1,199 
Total property, equipment and softwareTotal property, equipment and software$7,552 $6,554 Total property, equipment and software$7,413 $7,928 
Less accumulated depreciationLess accumulated depreciation(6,148)(6,197)Less accumulated depreciation(6,307)(6,229)
Total property, equipment and software, netTotal property, equipment and software, net$1,404 $357 Total property, equipment and software, net$1,106 $1,699 


For the nine months ended September 30, 20222023 and 2021,2022, depreciation (and amortization of software) expense was $0.1 million andapproximately $0.2 million, respectively.



NOTE 9. LEASES

We lease office space under contracts we classify as operating leases. None of our leases are financing leases.

The following table presents the detail of our lease expense, which is reported in General and administrative expense (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Operating lease expense$65 $73 $206 $236 
Short-term lease expense430 182 1,211 812 
Lease expense$495 $255 $1,417 $1,048 


We reported within operating cash flows forwhile during the nine months ended September 30, 2022 and 2021, $0.2 million and $0.2 million, respectively,depreciation (and amortization of cash paid for amounts included in the measurement of operating lease liabilities.software) expense was de minimis.

As ofDuring the nine months ended September 30, 2022, our operating leases2023, we determined that certain costs that we had a weighted-average remaining lease termcapitalized to software development in progress would no longer be recoverable and we recorded an impairment of approximately 13 months, and we used a weighted-average discount rate of approximately 13% to measure our operating lease liabilities.$0.2 million.


17




Maturity of Lease Liabilities

The following table presents information regarding the maturities of undiscounted remaining operating lease payments, with a reconciliation to the amount of the liabilities representing such payments as presented in our September 30, 2022 Consolidated Balance Sheet (in thousands):
Operating lease liabilities maturing during the next:
One year$116 
Two years26 
Total lease payments$142 
Less: Imputed interest/present value discount(9)
Present value of cash flows$133 
Lease liabilities on balance sheet:
Short-term (included in accrued expenses - Note 10)
$108 
Long-term25 
Total lease liabilities$133 


Significant Judgments

When accounting for our leases, we make certain judgments, such as whether a contract contains a lease or what discount rate to use, that affect the determination of the amount of our lease assets and liabilities. Based on the current facts and circumstances related to our contracts, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted.


NOTE 10.9. ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES

The following table presents the components of Accrued expense and other current liabilities (in thousands):
September 30, 2022December 31, 2021September 30, 2023December 31, 2022
Accrued compensation and benefit-related expenseAccrued compensation and benefit-related expense$1,109 $821 Accrued compensation and benefit-related expense$2,822 $1,448 
Accrued interestAccrued interest713 385 Accrued interest633 769 
Other accrued expenseOther accrued expense1,368 1,073 Other accrued expense3,302 2,393 
Other payablesOther payables2,145 2,324 Other payables2,018 2,234 
Registration rights agreement penalty (see Note 12)
800 600 
Operating lease liability - currentOperating lease liability - current108 187 Operating lease liability - current367 138 
China Cash Bonuses (see Note 13)
99 439 
China Cash Bonuses (see Note 15)
China Cash Bonuses (see Note 15)
14 32 
Other current liabilitiesOther current liabilities228 134 Other current liabilities197 208 
TotalTotal$6,570 $5,963 Total$9,353 $7,222 


18


NOTE 11.10. NOTES PAYABLE (IN DEFAULT)(PAST DUE)

The following table presents our notes payable (in thousands) as of:
September 30, 2022December 31, 2021
Principal balance of Mudrick Loans$14,418 $30,000 
Unamortized discount and debt issuance cost— (2,189)
Notes payable, net of unamortized discount and debt issuance cost$14,418 $27,811 
September 30, 2023December 31, 2022
Principal balance of New Mudrick Notes (September 30, 2023) and Original Mudrick Loans (December 31, 2022)$16,307 $14,418 
Other notes payable165 189 
Notes payable, net of unamortized discount and debt issuance cost$16,472 $14,607 


On December 3, 2021, we entered into senior secured loan agreements (the “Original Mudrick Loan Agreements” and as amended by the First Amendment (as defined below), the “Mudrick Loan Agreements”) with certain of our subsidiaries as guarantors (the “Guarantors”) and certain institutional lenders affiliated with Mudrick Capital Management, LP (collectively, “Mudrick”), pursuant to which Mudrick extended credit to us consisting of term loans in the aggregate principal amount of $30.0 million (as amended, the “Mudrick(the “Original Mudrick Loans”). The Original Mudrick Loans as amended, bearbore interest at 16.5% per annum until the original maturity date of July 31, 2022 and, following an amendment we entered into with Mudrick in August 2022, bore interest at 18.5% per annum (originally 16.5%annum. The amendment also extended the maturity date of the Original Mudrick Loans from July 31, 2022 to October 31, 2022. However, we did not make the required repayment of the Original Mudrick Loans by October 31, 2022, which constituted an event of default under the Original Mudrick Loans and triggered an increase in the interest rate under the Original Mudrick Loans to 20.5%.

In connection with our entry into the Original Mudrick Loan Agreements, we paid Mudrick an upfront fee equal to 5.0% of the amount of the Original Mudrick Loans, which amount was netted against the drawdown of the Original Mudrick Loans. We recorded the upfront fee as a debt discount of $1.5 million, and recorded debt issuance cost totaling $1.1 million. We amortized the discount on the Original Mudrick Loans and the debt issuance cost over the life of the Original Mudrick Loans and, during the year ended December 31, 2022, we amortized $2.2 million of such discount and debt issuance cost.

During the year ended December 31, 2022, we repaid $6.2 million of the principal amount of the Original Mudrick Loans in cash and delivered all of our shares in Sharecare, Inc. to Mudrick on July 11, 2022, in partial settlement of the Original Mudrick Loans, resulting in a further repayment of approximately $9.7 million of the principal amount of the Original Mudrick Loans. As of December 31, 2022, the outstanding balance of the Original Mudrick Loans was $14.4 million, and approximately $0.8 million of accrued interest was included in Accrued expense and other current liabilities. During the three months ended March 31, 2023, prior to the New Mudrick Loan Agreement (defined below) canceling the Original Mudrick Loans, we accrued approximately $0.6 million additional interest expense on the Original Mudrick Loans, of which $0.3 million was paid during such period.

18


On March 14, 2023, we entered into a Note Purchase Agreement (the “New Mudrick Loan Agreement”) with Mudrick, pursuant to which all of the Original Mudrick Loans were cancelled in exchange for new notes payable to Mudrick (the “New Mudrick Notes”) in the aggregate principal amount of approximately $16.3 million. The principal balance of the New Mudrick Notes included the $14.4 million outstanding balance of the Original Mudrick Loans, plus $1.1 million of accrued interest on the Original Mudrick Loans, plus a fee of approximately $0.8 million payable to Mudrick as consideration for cancelling the Original Mudrick Loans and converting all amounts outstanding thereunder into the New Mudrick Notes. We recorded the $0.8 million as interest expense during the three months ended March 31, 2023.

The New Mudrick Notes bear interest at a rate of 20.5% per annum),annum, which is payable on the last business day of each month.month commencing on May 31, 2023. The interest rate will increase by 2% and the principal amount outstanding under the New Mudrick Notes and any unpaid interest thereon may become immediately due and payable upon the occurrence of any event of default under the New Mudrick Loan Agreement. All amounts outstanding under the New Mudrick Loans, as amended,Notes, including all accrued and unpaid interest, will bebecame due and payable in full on October 31, 2022 (originally due on July 31, 2022). 2023.

To secure the payment and performance of the obligations under the Original Mudrick Loan Agreements and the New Mudrick Loan Agreement, we, together with the Guarantors,certain of our subsidiaries (the “Guarantors”), have granted to TMI Trust Company, as the collateral agent for the benefit of Mudrick, a first priority lien on, and security interest in, all assets of Remark and the Guarantors, subject to certain customary exceptions. The Mudrick Loan Agreements contain representations, warranties, events of default, indemnifications and other provisions customary for financings of this type. The occurrence of any event of default under the Mudrick Loan Agreements may result in the principal amount outstanding and unpaid interest thereon becoming immediately due and payable.

In connection with our entry into the Mudrick Loan Agreements, we paid to Mudrick an upfront fee equal to 5.0% of the amount of the Mudrick Loans, which amount was netted against the drawdown of the Mudrick Loans. We recorded the upfront fee as a debt discount of $1.5 million, and recorded debt issuance cost totaling $1.1 million. We amortized the discount on the Mudrick Loans and the debt issuance cost over the life of the Mudrick Loans and, during the nine months ended September 30, 2022, we amortized $2.2 million of such discount and debt issuance cost.

On August 3, 2022, we entered into a First Amendment to the Original Mudrick Loan Agreements (the “First Amendment”), pursuant to which, Mudrick agreed, among other things, to (i) waive certain existing events of default under the Mudrick Loan Agreements, (ii) extend the original July 31, 2022 maturity date to October 31, 2022 (provided, however, that if we prepay the principal amount of the loans in an amount of at least $5 million, the maturity date will be automatically extended to November 30, 2022), and (iii) defer payment of interest for the month of July 2022 to August 31, 2022. In addition, on and after the effective date of the First Amendment, the outstanding loans under the Mudrick Loan Agreements will bear interest at 18.5% per annum, payable on the last business day of each month commencing on August 31, 2022. We have also agreed to commence marketing and sale efforts with respect to our Bikini.com business. In consideration for Mudrick’s agreement to enter into the First Amendment and extend the maturity date, we agreed to pay Mudrick an amendment and extension payment in the amount of 2.0% of the unpaid principal balance of the loans outstanding as of the date of the First Amendment, or approximately $0.3 million, which was added to the principal balance of the loans as of the effective date of the First Amendment.

We did not make the required repaymentrepayments of the outstanding loans under the New Mudrick Loan Agreements by October 31, 2022, the maturity date. This constitutes an eventAgreement that were due beginning on June 30, 2023, which constitute events of default for which we have not received a waiver as of the date of this Form 10-Q. While we are actively engaged in discussions with Mudrick regarding a resolution of the eventevents of default and have made progress in such discussions, we cannot provide any assurance that we will be successful in obtaining a waiver or that Mudrick will continue to forebear from taking any enforcement actions against us.

During
Other Notes Payable

The Other notes payable in the nine months ended September 30, 2022, we repaid $6.2 milliontable above represent individually immaterial notes payable issued for the purchase of principal and, as described in more detail in Note 6, we delivered all remaining shares of New Sharecare to Mudrick on July 11, 2022, in partial settlement of the Mudrick Loans, resulting inoperating assets. Such notes payable bear interest at a reductionweighted-average interest rate of approximately $9.7 million6.2% and have a weighted-average remaining term of principal.approximately 4.5 years.


19


NOTE 11. OBLIGATIONS TO ISSUE COMMON STOCK (TRANSACTIONS WITH IONIC)

Convertible Debentures

On October 6, 2022, we entered into a debenture purchase agreement (the “2022 Debenture Purchase Agreement”) and a purchase agreement (the “ELOC Purchase Agreement”) with Ionic. Pursuant to the 2022 Debenture Purchase Agreement, we issued a convertible subordinated debenture in the original principal amount of approximately $2.8 million (the “2022 Debenture”) to Ionic for a purchase price of $2.5 million. The 2022 Debenture automatically converted into shares of our common stock (the “2022 Debenture Settlement Shares”) on November 17, 2022 upon the effectiveness of a registration statement we filed pursuant to a registration rights agreement we entered into with Ionic. Upon issuance of the 2022 Debenture, we initially estimated the obligation to issue common stock at approximately $3.6 million. As of December 31, 2022, we estimated such obligation to have a fair value of $1.9 million, representing an additional 1,720,349 shares to be issued pursuant to the 2022 Debenture. When the measurement period for determining the conversion price of the 2022 Debenture was completed, we determined that the final number of 2022 Debenture Settlement Shares would be 3,129,668 (inclusive of 898,854 shares that were issued during 2022), resulting in the issuance of an additional 2,230,814 shares during 2023 with a fair value of $3.1 million.

On March 14, 2023, we entered into a new debenture purchase agreement (the “2023 Debenture Purchase Agreement”) with Ionic pursuant to which we authorized the issuance and sale of two convertible subordinated debentures in the aggregate principal amount of approximately $2.8 million for an aggregate purchase price of $2.5 million. The first debenture is in the original principal amount of approximately $1.7 million for a purchase price of $1.5 million (the “First 2023 Debenture”), which was issued on March 14, 2023, and the second debenture is in the original principal amount of approximately $1.1 million for a purchase price of $1.0 million (the “Second 2023 Debenture” and collectively with the First Debenture, the “2023 Debentures”), which was issued on April 12, 2023. Upon issuance of the First 2023 Debenture and the Second 2023 Debenture, we initially estimated the obligations to issue common stock at an aggregate of approximately $4.1 million, or equivalent estimated issuable shares of 3,669,228. As of September 30, 2023, we estimated that an aggregate total of 9,373,457 shares would be issued upon conversion in full of the 2023 Debentures, representing obligations with an aggregate fair value of $4.7 million.

The 2023 Debentures accrue interest at a rate of 10% per annum, of which two years of interest is guaranteed and deemed earned in full on the first day following the issuance date. The interest rate on the 2023 Debentures increases to a rate of 15% per annum if the 2023 Debentures are not fully paid, converted or redeemed by the second anniversary of each debenture (each, a “Maturity Date”) or upon the occurrence of certain trigger events, including, but not limited to, the suspension from trading or the delisting of our common stock from Nasdaq for three consecutive trading days. If the 2023 Debentures are not fully paid or converted by their respective Maturity Dates, the original aggregate principal amount of the 2023 Debentures will be deemed to have been approximately $3.3 million from their issuance dates.

The 2023 Debentures automatically convert into shares of common stock at the earlier of (i) the effectiveness of the initial registration statement registering the resale of certain Registrable Securities as such term is defined in the Registration Rights Agreement (as defined below) including, without limitation, the shares issuable upon conversion of the 2023 Debentures (the “Conversion Shares”) (such registration statement, the “Resale Registration Statement”), and (ii) 181 days after the issuance date of each 2023 Debenture. The number of shares of common stock issuable upon conversion of each 2023 Debenture shall be determined by dividing the outstanding balance under each 2023 Debenture (including all accrued and unpaid interest and accrued and unpaid late charges, if any) by a conversion price that is the lower of (x) 80% (or 70% if our common stock is not then trading on Nasdaq) of the average of the two lowest VWAPs over a specified measurement period following the conversion date (the “Variable Conversion Price”), and (y) $1.40 (the “Fixed Conversion Price”), subject to full ratchet anti-dilution protection in the event we issue certain equity securities at a price below the then Fixed Conversion Price. The 2023 Debentures are unsecured and expressly junior to any of our existing or future debt obligations. Notwithstanding anything to the contrary, under no circumstances shall the Variable Conversion Price be less than the floor price of $0.20 as specified in the 2023 Debentures. Additionally, in the event of a bankruptcy, we are required to redeem the 2023 Debentures in cash in an amount equal to the then outstanding balance of the 2023 Debentures multiplied by 120%. The 2023 Debentures further provide that we will not effect the conversion of any portion of the 2023 Debentures, and the holder thereof will not have the right to a conversion of any portion of the 2023 Debentures, to the extent that after giving effect to such conversion, the holder together with its affiliates would beneficially own more than 4.99% of the outstanding shares of our common stock immediately after giving effect to such conversion. Furthermore, we may not issue shares of common stock underlying the 2023 Debentures if such issuance would require us to obtain stockholder approval under the Nasdaq rules or until such stockholder approval has been obtained.

Concurrently with entering into the 2023 Debenture Purchase Agreement, we also entered into a registration rights agreement with Ionic (the “2023 Registration Rights Agreement”), pursuant to which we agreed to file with the SEC one or more registration statements, as necessary, and to the extent permissible and subject to certain exceptions, to register under the
20


Securities Act of 1933, as amended, the resale of the shares of our common stock issuable upon conversion of the 2023 Debentures and the shares of common stock that may be issued to Ionic if we fail to comply with our obligations in the 2023 Registration Rights Agreement. The 2023 Registration Rights Agreement required that we file, within 15 calendar days after we filed our 2022 Form 10-K, a resale registration statement and use commercially reasonable efforts to have such resale registration statement declared effective by the SEC on or before the earlier of (i) 90 days after signing of the 2023 Registration Rights Agreement (or 120 days if such registration statement was subject to full review by the SEC) and (ii) the 2nd business day after we were notified we would not be subject to further SEC review. If we failed to file or have the resale registration statement declared effective by the specified deadlines, then in each instance, we would be required to issue to Ionic 150,000 shares of our common stock within two trading days after such failure, and with respect to the Conversion Shares, we would additionally pay in cash, as liquidated damages, an amount equal to 2% of the amount then currently outstanding under the 2023 Debentures for failure to file and have the Resale Registration Statement declared effective by the same deadlines set forth above for each 30-day period after each such failure. The Resale Registration Statement was filed on June 16, 2023 and declared effective on June 26, 2023. Because we did not meet the filing and effectiveness deadlines specified in the Registration Rights Agreement, we issued 300,000 shares of our common stock shares to Ionic in July 2023, fulfilling the liability of approximately $0.3 million that was outstanding as of June 30, 2023.


Equity Line of Credit

The ELOC Purchase Agreement, as amended (see below), provides that, upon the terms and subject to the conditions and limitations set forth therein, we have the right to direct Ionic to purchase up to an aggregate of $50.0 million of shares of our common stock over the 36-month term of the ELOC Purchase Agreement. Under the ELOC Purchase Agreement, after the satisfaction of certain commencement conditions, including, without limitation, the effectiveness of a resale registration statement filed with the SEC registering such shares and that the 2022 Debenture shall have been fully converted into shares of common stock or shall otherwise have been fully redeemed and settled in all respects in accordance with the terms of the 2022 Debenture, we have the right to present Ionic with a purchase notice (each, a “Purchase Notice”) directing Ionic to purchase any amount up to $3.0 million of our common stock per trading day, at a per share price equal to 90% (or 80% if our common stock is not then trading on Nasdaq) of the average of the two lowest volume-weighted average prices (“VWAPs”) over a specified measurement period. With each purchase under the ELOC Purchase Agreement, we are required to deliver to Ionic an additional number of shares equal to 2.5% of the number of shares of common stock deliverable upon such purchase. The number of shares that we can issue to Ionic from time to time under the ELOC Purchase Agreement shall be subject to the condition that we will not sell shares to Ionic to the extent that Ionic, together with its affiliates, would beneficially own more than 4.99% of the outstanding shares of our common stock immediately after giving effect to such sale (the “Beneficial Ownership Limitation”).

In addition, Ionic will not be required to buy any shares of our common stock pursuant to a Purchase Notice on any trading day on which the closing trade price of our common stock is below $0.20 (as amended by the Letter Agreement, as defined below). We will control the timing and amount of sales of our common stock to Ionic. Ionic has no right to require any sales by us, and is obligated to make purchases from us as directed solely by us in accordance with the ELOC Purchase Agreement. The ELOC Purchase Agreement provides that we will not be required or permitted to issue, and Ionic will not be required to purchase, any shares under the ELOC Purchase Agreement if such issuance would violate Nasdaq rules, and we may, in our sole discretion, determine whether to obtain stockholder approval to issue shares in excess of 19.99% of our outstanding shares of common stock if such issuance would require stockholder approval under Nasdaq rules. Ionic has agreed that neither it nor any of its agents, representatives and affiliates will engage in any direct or indirect short-selling or hedging our common stock during any time prior to the termination of the ELOC Purchase Agreement.

The ELOC Purchase Agreement may be terminated by us at any time after commencement, at our discretion; provided, however, that if we sold less than $25.0 million to Ionic (other than as a result of our inability to sell shares to Ionic as a result of the Beneficial Ownership Limitation, our failure to have sufficient shares authorized or our failure to obtain stockholder approval to issue more than 19.99% of our outstanding shares), we will pay to Ionic a termination fee of $0.5 million, which is payable, at our option, in cash or in shares of common stock at a price equal to the closing price on the day immediately preceding the date of receipt of the termination notice. Further, the ELOC Purchase Agreement will automatically terminate on the date that we sell, and Ionic purchases, the full $50.0 million amount under the agreement or, if the full amount has not been purchased, on the expiration of the 36-month term of the ELOC Purchase Agreement.

On January 5, 2023, we and Ionic entered into a letter agreement (the “Letter Agreement”) which amended the ELOC Purchase Agreement. Under the Letter Agreement, the parties agreed, among other things, to (i) amend the floor price below which Ionic will not be required to buy any shares of our common stock under the ELOC Purchase Agreement from $0.25 to $0.20, determined on a post-reverse split basis, (ii) amend the per share purchase price for purchases under the ELOC Purchase Agreement to 90% of the average of the two lowest daily VWAPs over a specified measurement period, which will commence
21


at the conclusion of the applicable measurement period related to the 2022 Debenture and (iii) waive certain requirements in the ELOC Purchase Agreement to allow for a one-time $0.5 million purchase under the ELOC Purchase Agreement.

As partial consideration for the waiver to allow for the $0.5 million purchase by Ionic, we agreed to issue to Ionic that number of shares (the “Letter Agreement Shares”) equal to the difference between (x) the variable conversion price in the 2022 Debenture, and (y) the calculation achieved as a result of the following formula: 80% (or 70% if our common stock is not then trading on Nasdaq) of the lowest VWAP starting on the trading day immediately following the receipt of pre-settlement conversion shares following the date on which the 2022 Debenture automatically converts or other relevant date of determination and ending the later of (a) 10 consecutive trading days after (and not including) the Automatic Conversion Date (as defined in the ELOC Agreement) or such other relevant date of determination and (b) the trading day immediately after shares of our common stock in the aggregate amount of at least $13.9 million shall have traded on Nasdaq. As of March 31, 2023, we estimated the obligation to issue the Letter Agreement Shares at approximately $0.2 million. As of June 30, 2023, we had issued all of the 200,715 Letter Agreement Shares.

During the nine months ended September 30, 2023, Ionic advanced to us an aggregate of $7.0 million (the "ELOC Advances") pursuant to the ELOC Agreement, as amended. Upon issuance of the ELOC Advances, we initially estimated the obligations to issue common stock at approximately $10.5 million, or equivalent estimated issuable shares of 11,326,803. In partial settlement of our obligation to issue common stock under the ELOC Advances, we issued 5,343,762 shares of our common stock during the period ended September 30, 2023 at aggregate fair value of approximately $5.2 million. As of September 30, 2023, we estimated that an additional 9,046,830 shares would be issued in settlement of our obligation to issue common stock under the ELOC Advances, representing an obligation with an aggregate fair value of $4.5 million.

On September 15, 2023, we and Ionic entered into a letter agreement (the “September 2023 Letter Agreement”) which amends the ELOC Purchase Agreement, as previously amended on January 5, 2023. Under the September 2023 Letter Agreement, the parties agreed, among other things, to (i) allow Remark to deliver one or more irrevocable written notices (“Exemption Purchase Notices”) to Ionic in a total aggregate amount not to exceed $20.0 million, which total aggregate amount shall be reduced by the aggregate amount of previous Exemption Purchase Notices, (ii) amend the per share purchase price for purchases under an Exemption Purchase Notice to 80% of the average of the two lowest daily volume-weighted average prices (“VWAPs”) over a specified measurement period, (iii) amend the definition of the specified measurement period to stipulate that, for purposes of calculating the final purchase price, such measurement period begins the trading day after Ionic pays Remark the amount requested in the purchase notice, while the calculation of the dollar volume of Remark common stock traded on the principal market to determine the length of the measurement period shall begin on the trading day after the previous measurement period ends, iv) that any additional Exemption Purchase Notices that are not in accordance with the terms and provisions of the Purchase Agreement shall be subject to Ionic’s approval, v) to amend section 11(c) of the ELOC Purchase Agreement to increase the Additional Commitment Fee from $0.5 million to $3.0 million and vi) that by September 29, 2023, the parties will amend the Debenture Transaction Documents to include a so-called Most Favored Nation provision that will provide Ionic with necessary protection against any future financing, settlement, exchange or other transaction whether with an existing or new lender, investor or counterparty, and that, if such amendment is not made by September 29, 2023, the Additional Commitment Fee shall be further increased to approximately $3.8 million.


Accounting for the Debentures and the ELOC

Using the guidance in ASC Topic 480, Distinguishing Liabilities from Equity, we evaluated the 2022 Debenture Purchase Agreement and its associated 2022 Debenture, the 2023 Debenture Purchase Agreement and its associated First 2023 Debenture, and the ELOC Purchase Agreement and its associated Letter Agreement and ELOC Advance, and determined that all represented obligations that must or may be settled with a variable number of shares, the monetary value of which was based solely or predominantly on a fixed monetary amount known at inception. Using a Level 3 input, we estimated the number of shares of our common stock that we would have to issue for each obligation and multiplied the estimated number of shares by the closing market price of our common stock on the measurement date to determine the fair value of the obligation. We then recorded the amount of the initial obligation in excess of the purchase price as finance cost. We remeasure each obligation at every balance sheet date until all shares representing the obligation have been issued, with the change in the amount of the obligation being recorded as finance cost. The following table shows the changes in our obligations to issue common stock (dollars in thousands):
22



2022 Debenture2023 DebenturesFiling & Effectiveness DefaultLetter AgreementELOC AdvancesTotal
Obligations to Issue Common Stock
Balance at December 31, 2022$1,892 $— $— $— $— $1,892 
Establishment of new obligation to issue shares— 4,109 332 249 10,483 15,173 
Issuance of Shares(3,138)(94)(294)(227)(5,167)(8,920)
Change in measurement of liability1,246 658 (38)(22)(805)1,039 
Balance at September 30, 2023$— $4,673 $— $— $4,511 $9,184 
Estimated Number of Shares Issuable
Balance at December 31, 20221,720,349 — — — — 1,720,349 
Establishment of new obligation to issue shares— 3,669,228 300,000 200,715 11,326,803 15,496,746 
Issuance of Shares(2,230,814)(97,000)(300,000)(200,715)(5,343,762)(8,172,291)
Change in estimated number of shares issuable510,465 5,801,229 — — 3,063,789 9,375,483 
Balance at September 30, 2023— 9,373,457 — — 9,046,830 18,420,287 


The following table shows the composition of finance cost associated with our obligations to issue common stock (dollars in thousands):

2022 Debenture2023 DebenturesFiling & Effectiveness DefaultLetter AgreementELOC AdvancesTotal
Initial obligation in excess of purchase price$— $1,609 $332 $249 $3,483 $5,673 
Change in measurement of liability1,246 658 (38)(22)(805)1,039 
Total$1,246 $2,267 $294 $227 $2,678 $6,712 


NOTE 12. COMMITMENTS AND CONTINGENCIES

At September 30, 2022,2023, we had no material commitments outside the normal course of business.


Contingencies

As of September 30, 2022,2023, we were neither a defendant in any material pending legal proceeding nor are we aware of any material threatened claims against us and, therefore, we have not accrued any contingent liabilities.


Registration Rights Agreement

On September 27, 2021, we entered into a securities purchase agreement (the “Armistice Purchase Agreement”) with Armistice Capital Master Fund Ltd. (“Armistice Capital”) pursuant to which we issued shares of our common stock together with warrants to purchase our common stock, subject to certain customary anti-dilution adjustments (the “Armistice Warrants”).

In connection with our entry into the Armistice Purchase Agreement, we also entered into a registration rights agreement with Armistice Capital, pursuant to which we arewere obligated to file one or more registration statements, as necessary, to register under the Securities Act of 1933, as amended, the resale of the shares we issued to Armistice Capital and the shares underlying the Armistice Warrants (collectively, the “Armistice Registrable Securities”) and to obtain effectiveness of such registration statement no later than 90 days following September 27, 2021. The registration statementrights agreement provided that if we filedfailed to register the resale of the Armistice Registrable Securities was declared effective on October 31, 2022 (the “Armistice Resale Registration Statement”). As of September 30, 2022, we had already accrued a total of $1.0 million, equal to the maximum amount of liquidated damages we are required to pay under the Armistice Registration Rights Agreement for failing to satisfy our obligation to timely obtain effectiveness of the Armistice Resale Registration Statement. During the nine months ended September 30, 2022, we paid $0.2 million of this amount, resulting in an unpaid amount of $0.8 million included in other accrued expense at September 30, 2022.


Bid Price Deficiency

On February 25, 2022, we received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that, for a period of 30 consecutive business days, the bid price of our common stock closed below the minimum of $1.00 per share required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we had 180 calendar days, or until August 24, 2022, to regain compliance with the Bid Price Rule.

On August 30, 2022, we received a staff determination letter from Nasdaq stating that we did not regain compliance with the Bid Price Rule and we were not eligible for a second 180-day grace period because we did not comply with the minimum $5,000,000 Stockholders’ Equity initial listing requirement for the Nasdaq Capital Market. We appealed Nasdaq’s delisting determination to a Hearings Panel (the “Panel”), which heard our presentation at a hearing held on October 6, 2022.

On October 17, 2022, we received a written decision from the Panel granting our request for continued listing on Nasdaq, subject to the conditions that, on January 11, 2023, we will have demonstrated compliance with the Bid Price Rule by evidencing a closing price of $1.00 or more per share for a minimum of 10 consecutive trading sessions, and that we provide prompt notification of any significant events that occur during the period ending on January 11, 2023 that may affect our compliance with Nasdaq rules.


2023


satisfy our obligation to timely obtain effectiveness, we would incur a penalty of as much as $1.0 million. The registration statement to register the resale of the Armistice Registrable Securities was declared effective on October 31, 2022. We had accrued the maximum penalty and, as of December 31, 2022, paid $0.2 million of such amount, resulting in an unpaid amount of $0.8 million included in other accrued expense as of September 30, 2023.


NOTE 13. STOCKHOLDERS' EQUITY (DEFICIT)DEFICIT

Warrants

The following table summarizes information related to our equity-classified stock warrant issuances as of and for the dates and periods noted:
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 202110,114,408 $4.01 4.7$— 
Outstanding at December 31, 2022Outstanding at December 31, 20221,011,441 $40.10 3.7$— 
GrantedGranted— — Granted— — 
ExercisedExercised— — Exercised— — 
Forfeited, cancelled or expiredForfeited, cancelled or expired— — Forfeited, cancelled or expired— — 
Outstanding at September 30, 202210,114,408 $4.01 3.9$— 
Outstanding at September 30, 2023Outstanding at September 30, 20231,011,441 $40.10 2.9$— 


Share-Based Compensation 

On September 2, 2022, we issued 1,250,000 shares of our common stock with a fair value of $0.5 million to a vendor in exchange for services performed.

We are authorized to issue equity-based awards under our 2014 Incentive Plan, our 2017 Incentive Plan and our 2022 Incentive Plan, each of which our stockholders have approved. We also award cash bonuses (“China Cash Bonuses”) to our employees in China, which grants are not subject to a formal incentive plan and which can only be settled in cash. We grant such awards to attract, retain and motivate eligible officers, directors, employees and consultants. Under each of the plans, we have granted shares of restricted stock and options to purchase common stock to our officers and employees with exercise prices equal to or greater than the fair value of the underlying shares on the grant date.

Stock options and China Cash Bonuses generally expire 10 years from the grant date. All forms of equity awards and China Cash Bonuses vest upon the passage of time, the attainment of performance criteria, or both. When participants exercise stock options, we issue any shares of our common stock resulting from such exercise from new authorized and unallocated shares available at the time of exercise.

24


The following table summarizes activity under our equity incentive plans related to equity-classified stock option grants as of and for the dates and periods noted:
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 202114,839,020 $3.30 6.1$159 
Granted384,732 0.49 
Exercised— — 
Forfeited, cancelled or expired(100,000)1.41 
Outstanding at September 30, 202215,123,752 $3.25 5.4$— 
Exercisable at December 31, 202112,776,520 3.62 5.7$957 
Exercisable at September 30, 202214,334,752 3.35 5.3$— 
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20221,626,631 $30.31 5.5$
Granted— — 
Exercised— — 
Forfeited, cancelled or expired(3,285)46.75 
Outstanding at September 30, 20231,623,346 $30.28 5.0$— 
Exercisable at December 31, 20221,549,681 31.41 5.3$
Exercisable at September 30, 20231,601,649 30.79 4.6$— 

21



The following table summarizes activity related to our liability-classified China Cash Bonuses as of and for the dates and periods noted:
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20211,036,000 $3.97 5.4$159 
Forfeited, cancelled or expired(299,500)4.69 
Outstanding at September 30, 2022736,500 $3.68 6.2$— 
Exercisable at December 31, 2021886,000 4.41 4.9$— 
Exercisable at September 30, 2022676,500 3.88 6.1$— 
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 202271,450 $35.99 6.1$— 
Granted— — 
Exercised— — 
Forfeited, cancelled or expired— — 
Outstanding at September 30, 202371,450 $35.99 5.4$— 
Exercisable at December 31, 202268,450 36.97 6.1$— 
Exercisable at September 30, 202371,450 35.99 5.4$— 


The following table presents the change in the liability associated with our China Cash Bonuses included in Accrued expense and other current liabilities (in thousands):
Nine Months Ended September 30,Year Ended December 31,Nine Months Ended September 30,Year Ended December 31,
2022202120232022
Balance at beginning of periodBalance at beginning of period$439 $679 Balance at beginning of period$32 $439 
Share-based compensation expense related to China Cash BonusesShare-based compensation expense related to China Cash Bonuses(340)(240)Share-based compensation expense related to China Cash Bonuses(18)(407)
Balance at end of periodBalance at end of period$99 $439 Balance at end of period$14 $32 


On July 27, 2020, the compensation committee of our board of directors approved grants to employees, directors and other service providers, excluding our CEO, of options to purchase approximately 5.4 million shares of our common stock. The option agreements governing the grants contain a stipulation that, regardless of vesting, such options do not become exercisable unless and until stockholders approve an amendment to our Amended and Restated Certificate of Incorporation to increase in the number of authorized shares of our common stock in an amount sufficient to allow for the exercise of the options and we have filed a corresponding Certificate of Amendment to our Amended and Restated Certificate of Incorporation reflecting such increase in the number of authorized shares of our common stock.

On July 8, 2021, our stockholders approved an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common stock to 175,000,000, and we filed a Certificate of Amendment to our Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on July 9, 2021 to reflect this amendment, which became effective immediately upon filing.

As a result of the increase in the number of authorized shares of our common stock, we determined that July 8, 2021 was the grant date for accounting purposes of the stock options we originally issued on July 27, 2020. The grant date fair value of the options granted on July 27, 2020 was approximately $6.3 million. To estimate the fair value of the options with an accounting grant date of July 8, 2021, we used the Black-Scholes-Merton option pricing model with an expected volatility of 85%, a risk-free interest rate of 0.34%, and expected term of six years and no expected dividends.

Effective as of January 25, 2022, we entered into a one-year agreement with a consultant that requires us to issue to him each month an option to purchase shares of our common stock. The number of shares purchasable under each option contract to be granted is based upon certain agreed terms and assumptions, and each such option contract is intended to compensate the consultant with an aggregate fair value of $15,000. As of September 30, 2022, we had issued to the consultant options to purchase 384,732 shares of our common stock, and such options collectively represented a total share-based compensation expense of approximately $0.1 million.

The following table presents a breakdown of share-based compensation cost included in operating expense (in thousands):
2225


Nine Months Ended September 30,
20222021
Stock options$1,525 $3,823 
China Cash Bonuses(340)(326)
Total$1,185 $3,497 
The following table presents a breakdown of share-based compensation cost included in operating expense (in thousands):
Nine Months Ended September 30,
20232022
Stock options$167 $1,525 
China Cash Bonuses(18)(340)
Total$149 $1,185 


We record share-based compensation expense in the books of the subsidiary that incurs the expense, while for equity-classified stock options we record the change in additional paid-in capital on the corporate entity because the corporate entity’s equity underlies such stock options.

The following table presents information regarding unrecognized share-based compensation cost associated with stock options and China Cash Bonuses:
September 30, 20222023
Unrecognized share-based compensation cost for non-vested awards (in thousands):
Stock options59731 
China Cash Bonuses7 
Weighted-average years over which unrecognized share-based compensation expense will be recognized:
Stock options0.31.4
China Cash Bonuses0.30


NOTE 14. RELATED PARTY TRANSACTIONS

As of September 30, 2022,2023, we owed approximately $0.9$1.0 million to members of management representing various operating expense payments made on our behalf. Approximately $0.5 million was repaid in October 2022.


NOTE 15. CHINA BUSINESS PARTNER

We interact with an unrelated entity (the “China Business Partner”) in more than one capacity. Firstly, since 2020, we have been working with the China Business Partner to earn revenue by obtaining business from some of the largest companies in China. Secondly, our artificial intelligence business in the U.S. has to date, purchased substantially all of its inventory from a subsidiary of the China Business Partner which manufactures certain equipment to our specifications; though, during the sixnine months ended September 30, 2022,2023, we did not make a material amount ofany such purchases. In addition, a member of our senior leadership team maintains a role in the senior management structure of the China Business Partner.

As of December 31, 2021, $4.0 million remained outstanding of the amount we advanced to the China Business Partner pursuant to an agreement between the two entities. Under the executed agreement, we had an obligation to advance as much as an aggregate amount of $5.1 million over the loan term of five years, and we could elect to convert amounts due to it under the agreement into equity of the China Business Partner upon any equity financing the China Business Partner undertook during the term of the agreement. The business purpose for the advances was to allow the China Business Partner to purchase and modify hardware to integrate with our software and market such integrated product to potential customers, including some of the largest companies in China. During the three months ended March 31, 2022, the China Business Partner repaid the advances in full.

During the three and nine months ended September 30, 2023 and 2022, we recognized approximately $1.9$0.1 million and $5.3 million, respectively, of revenue from the relationship with the China Business Partner. At September 30, 2023 and December 31, 2022, we had $3.0 million ofin addition to the outstanding accounts receivable balances from the China Business partner.Partner described in Note 5, we had outstanding accounts payable to the China Business Partner of $0.7 million and $0.7 million, respectively.


23


NOTE 16. SUBSEQUENT EVENTS

Ionic Transactions

On October 6, 2022, we entered into a debenture purchase agreement (the “Debenture Purchase Agreement”) withIn November 2023, Ionic Ventures, LLC (“Ionic”), pursuantadvanced to which we issued a convertible subordinated debenture in the original principal amount of $2,778,000 (the “Debenture”) to Ionic for a purchase price of $2,500,000. The Debenture accrues interest at a rate of 8% per annum. The interest rate on the Debenture increases to a rate of 15% per annum if the Debenture is not fully paid or converted by February 6, 2023 (the “Trigger Date”) or upon the occurrence of certain trigger events, including, without limitation, the suspension from trading or the delisting of our common stock from Nasdaq and the occurrence of any material adverse effect. In addition, if the Debenture is not fully paid or converted by the Trigger Date, the original principal amount of the Debenture will be deemed to have been $3,334,000 from the issuance date. The Debenture matures on June 6, 2023.

The Debenture automatically converts into shares of common stock at the earlier of (i) the effective date of a registration statement registering the resale of the shares which may be issued upon conversion of the Debenture andus approximately $0.6 million pursuant to the ELOC Purchase Agreement, (as defined below) (the “Ionic Resale Registration Statement”) and (ii) 181 days after the issuance date of the Debenture.as amended.

The numberDuring October 2023 and November 2023, we issued a total of shares of common stock issuable upon conversion of the Debenture shall be determined by dividing the outstanding balance under the Debenture (including all accrued and unpaid interest and accrued and unpaid late charges, if any) by a conversion price that is the lower of (x) 80% (or 70% if our common stock is not then trading on Nasdaq) of the average of the 10 lowest volume-weighted average prices (“VWAPs”) over a specified measurement period following the conversion date, and (y) $0.50 (the “Fixed Conversion Price”), subject to full ratchet anti-dilution protection in the event we issue certain equity securities at a price below the then Fixed Conversion Price.

On November 7, 2022, we entered into an amendment to the Debenture Purchase Agreement with Ionic, pursuant to which we and Ionic agreed to amend and restate the Debenture to provide that (i) in no event will the conversion price under the Debenture be below a floor price of $0.10 (such price, as may be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction, the “Floor Price”), and (ii) in the event the actual conversion price is less than the Floor Price, (A) Ionic will be entitled to that number of Settlement Conversion Shares issuable with an assumed conversion price equal to the Floor Price, and (B) we will be required to make a cash payment to Ionic on or prior to the Maturity Date of an amount that is calculated by subtracting the number of shares of common stock issuable at an assumed conversion price equal to the Floor Price from the number of shares of common stock issuable at the actual conversion price, multiplied by a price equal to the average of the 10 lowest VWAPs during the specified measurement period.

Additionally, in the event of a bankruptcy, we are required to redeem the Debenture in cash in an amount equal to the then outstanding balance of the Debenture multiplied by 120%, subject, however, to the provisions of a subordination and intercreditor agreement between Ionic and Mudrick. The Debenture further provides that we will not effect the conversion of any portion of the Debenture, and the holder thereof will not have the right to a conversion of any portion of the Debenture, to the extent that after giving effect to such conversion, the holder together with its affiliates would beneficially own more than 4.99% of the outstanding shares of our common stock immediately after giving effect to such conversion (the “Beneficial Ownership Limitation”).

Also, on October 6, 2022, we entered into a purchase agreement (the “ELOC Purchase Agreement”) with Ionic, which provides that, upon the terms and subject to the conditions and limitations set forth therein, we have the right to direct Ionic to purchase up to an aggregate of $50,000,000 of shares of our common stock over the 36-month term of the ELOC Purchase Agreement. Under the ELOC Purchase Agreement, after the satisfaction of certain commencement conditions, including, without limitation, the effectiveness of the Ionic Resale Registration Statement, and (ii) pursuant to the ELOC Purchase Agreement (collectively, the “Ionic Resale Registration Statement”) and that the Debenture shall have been fully converted into shares of common stock or shall otherwise have been fully redeemed and settled in all respects in accordance with the terms of the Debenture, we have the right to present Ionic with a purchase notice (each, a “Purchase Notice”) directing Ionic to purchase any amount up to $3,000,000 of our common stock per trading day, at a per share price (the “Purchase Price”) equal to 90% (or 80% if our common stock is not then trading on Nasdaq) of the average of the 5 lowest VWAPs over a specified measurement period. With each purchase under the ELOC Purchase Agreement, we are required to deliver to Ionic an additional number of shares equal to 2.5% of the number of shares of common stock deliverable upon such purchase.

24


In addition, Ionic will not be required to buy any shares of our common stock pursuant to a Purchase Notice on any trading day on which the closing trade price of our common stock is below $0.25. We will control the timing and amount of sales of our common stock to Ionic. Ionic has no right to require any sales by us, and is obligated to make purchases from us as directed solely by us in accordance with the ELOC Purchase Agreement. The ELOC Purchase Agreement provides that we will not be required or permitted to issue, and Ionic will not be required to purchase, any shares under the ELOC Purchase Agreement if such issuance would violate Nasdaq rules, and we may, in our sole discretion, determine whether to obtain stockholder approval to issue shares in excess of 19.99% of our outstanding shares of common stock if such issuance would require stockholder approval under Nasdaq rules. Ionic has agreed that neither it nor any of its agents, representatives and affiliates will engage in any direct or indirect short-selling or hedging our common stock during any time prior to the termination of the ELOC Purchase Agreement.

The ELOC Purchase Agreement may be terminated by us if certain conditions to commence have not been satisfied by December 31, 2022. The ELOC Purchase Agreement may also be terminated by us at any time after commencement, at our discretion; provided, however, that if we sold less than $25,000,000 to Ionic (other than as a result of our inability to sell1,220,000 shares to Ionic as a resultin partial settlement of the Beneficial Ownership Limitation, our failure to have sufficient shares authorized or our failure to obtain stockholder approval to issue more than 19.99% of our outstanding shares), we will pay to Ionic a termination fee of $500,000, which is payable, at our option, in cash or in shares of common stock at a price equal to the closing price on the day immediately preceding the date of receipt of the termination notice. Further, the ELOC Purchase Agreement will automatically terminate on the date that we sell, and Ionic purchases, the full $50,000,000 amount under the agreement or, if the full amount has not been purchased, on the expiration of the 36-month term of the ELOC Purchase Agreement.

Concurrently with entering into the Debenture Purchase Agreement and the ELOC Purchase Agreement, we also entered into a registration rights agreement with Ionic (the “Registration Rights Agreement”), in which we agreed to file with the SEC one or more registration statements, as necessary, and to the extent permissible and subject to certain exceptions, to register under the Securities Act of 1933, as amended, the resale of the shares of our common stock issuable upon conversion of the Debenture, the shares of common stock that may be issued to Ionic under the ELOC Purchase Agreement and the shares of common stock that may be issued to Ionic if we fail to comply with our obligations in the Registration Rights Agreement. The Registration Rights Agreement requires that we file, within 30 days after signing, the Ionic Resale Registration Statement and use commercially reasonable efforts to have the Ionic Resale Registration Statement declared effective by the SEC on or before the earlier of (i) 90 days after signing (or 120 if such registration statement is subject to full review by the SEC) and (ii) the 2nd business day after we are notified we will not be subject to further SEC review. If we fail to file or have the Ionic Resale Registration Statement declared effective by the specified deadlines, then in each instance, we will issue to Ionic 150,000 shares of our common stock within 2 trading days after such failure, and with respect to the Conversion Shares, we will additionally pay in cash, as liquidated damages, an amount equal to 2% of the amount then currently outstanding under the Debenture for failure to file and have the Ionic Resale Registration Statement declared effective by the same deadlines set forth above for each 30-day period after each such failure. We filed the Ionic Resale Registration Statement on November 7, 2022.

Nasdaq Hearing

On October 17, 2022, we received a written decision from the Nasdaq Hearings Panel granting our request for continued listing on Nasdaq, subject to the conditions that, on January 11, 2023, we will have demonstrated compliance with the Bid Price Rule by evidencing a closing price of $1.00 or more per share for a minimum of 10 consecutive trading sessions, and that we provide prompt notification of any significant events that occur during the period ending on January 11, 2023 that may affect our compliance with Nasdaq rules.

Mudrick Loans

On October 6, 2022, we entered into a Provisional Waiver and Consent Agreement (the “Mudrick Waiver”) to the Mudrick Loan Agreements. Pursuant to the Mudrick Waiver, Mudrick agreed, among other things, to (i) waive certain then-existing events of default under the Mudrick Loan Agreements, (ii) defer payment of interest for the months of July, August and September 2022 to October 6, 2022, the closing date of the Debenture Purchase Agreement, and (iii) consent to the issuance of the Debenture and the other transactions contemplated by the Debenture Purchase Agreement. In connection with the Mudrick Waiver, we became a party to a Subordination and Intercreditor Agreement with Mudrick and Ionic, pursuant to which Ionic agreed, among other things, that all of our obligations to Ionic under the Debenture will be fully and unconditionally junior and subordinate in right of cash payment to the prior satisfaction in full of our obligation to Mudrick.

25


We did not make the required repayment of the outstanding loans under the Mudrick Loan Agreements by October 31, 2022, the maturity date. This constitutes an event of default for which we have not received a waiver as of the date of this Form 10-Q. While we are actively engaged in discussions with Mudrick regarding a resolution of the event of default, we cannot provide any assurance that we will be successful in obtaining a waiver or that Mudrick will forebear from taking any enforcement actions against us. As of the date of this Form 10-Q, the principal amount outstanding, together with interest on the unpaid principal balance of the Mudrick Loan, is $14.7 million.Advances.
26



On November 18, 2023, we and Ionic entered into a letter agreement (the “November 2023 Letter Agreement”) which, among other things, amends the Subordinated Convertible Debenture, dated as of March 14, 2023, by and between Remark and Ionic (the “First 2023 Debenture”).

The November 2023 Letter Agreement amends the First 2023 Debenture to include language that requires us to notify Ionic if we enter into any new debt agreement after November 18, 2023 or modify any debt agreement that existed at November 18, 2023. If Ionic determines that the terms of such new or modified agreements are preferable to the terms of the First 2023 Debenture, Ionic can give us written notice to amend, within five days, the terms of the First 2023 Debenture, excluding principal and interest, to give Ionic the benefit of such preferable terms.


Failure to Maintain Continued Listing Standards

On April 27, 2023, we received a written notice from the Nasdaq Listing Qualifications Department notifying us that, pursuant to Nasdaq Listing Rule 5550(b)(3), we are required to maintain a minimum of $500,000 in net income from continuing operations in the most recently completed fiscal year, or two of the last three fiscal years (the “Net Income Standard”). Since our 2022 Form 10-K reported net loss from continuing operations, and as of April 25, 2023, we did not meet the alternative continued listing standards (collectively, with the Net Income Standard, the “Continued Listing Standards”) under Nasdaq Listing Rule 5550(b) of a minimum stockholders' equity of $2.5 million or minimum market value of listed securities of $35 million, we no longer comply with the Continued Listing Standards.

In accordance with Nasdaq Listing Rule 5810(c)(2)(A), on June 12, 2023 we submitted a plan to regain compliance with the Continued Listing Standards to the Nasdaq Listing Qualifications Department. On July 24, 2023, the Nasdaq Listing Qualifications Department notified us that it was granting us until October 24, 2023 (the “Extension Period”) to file a report with the SEC and Nasdaq stating that we have successfully executed our plan to regain compliance with the Continued Listing Standards and that we did in fact regain such compliance. We were not able to regain compliance with the Continued Listing Standards by October 24, 2023 and, on October 26, 2023, we received a staff determination letter from Nasdaq indicating that we did not regain compliance with the Continued Listing Standards and that, unless we request an appeal of Nasdaq’s determination, our common stock was subject to delisting.

We appealed Nasdaq’s delisting determination to a Hearings Panel (the “Panel”) and were notified by Nasdaq that we have been granted a hearing with the Panel on February 1, 2024. Our common stock will continue to be listed and traded on the Nasdaq Capital Market pending a decision by the Panel.
27


ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read our discussion and analysis of our financial condition and results of operations for the three and six months ended September 30, 20222023 in conjunction with our condensed consolidated financial statements and notes thereto set forth in Part I, Item 1 of this Quarterly Report on Form 10-Q. Such discussion and analysis includes forward-looking statements that involve risks and uncertainties and that are not historical facts, including statements about our beliefs and expectations. You should also read Business, Risk Factors and Special Note Regarding Forward-Looking Statements in this Form 10-Q.


OVERVIEW

We are a diversified global technology business with leading AI and data-analytics, as well as a portfolio of digital media properties.


OUR BUSINESS

Corporate Structure

We are a holding company incorporated in Delaware and not a Chinese operating company. As a holding company, we conduct most of our operations through our subsidiaries, each of which is wholly owned. We haveUntil September 2022, we had historically conducted a significant part of our operations through contractual arrangements between our WFOE and certain VIEs based in China to address challenges resulting from laws, policies and practices that may disfavor foreign-owned entities that operate within industries deemed sensitive by the Chinese government. We were the primary beneficiary of the VIEs because the contractual arrangements governing the relationship between the VIEs and our WFOE, which included an exclusive call option agreement, exclusive business cooperation agreement, a proxy agreement and an equity pledge agreement, enabled us to (i) exercise effective control over the VIEs, (ii) receive substantially all of the economic benefits of the VIEs, and (iii) have an exclusive call option to purchase, at any time, all or part of the equity interests in and/or assets of the VIEs to the extent permitted by Chinese laws. Because we were the primary beneficiary of the VIEs, we consolidated the financial results of the VIEs in our consolidated financial statements in accordance with GAAP.

We terminated all of the contractual arrangements between the WFOE and the VIEs and exercised our rights under the exclusive call option agreements between the WFOE and the VIEs such that, effective as of September 19, 2022, we obtained 100% of the equity ownership of the entities we formerly consolidated as VIEs and which we now consolidate as wholly-owned subsidiaries.

The following diagram illustrates our corporate structure, including our significant subsidiaries, as of the date of this Form 10-Q. The diagram omits certain entities which are immaterial to our results of operations and financial condition.


2728Financial Statement Index


Remark Org Chart - Oct 2022 No VIE.jpg


We are subject to certain legal and operational risks associated with having a significant portion of our operations in China. Chinese laws and regulations governing our current business operations, including the enforcement of such laws and regulations, are sometimes vague and uncertain and can change quickly with little advance notice. The Chinese government may intervene in or influence the operations of our China-based subsidiaries at any time and may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in our operations and/or the value of our securities. In addition, any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors and cause the value of such securities to
2829Financial Statement Index


significantly decline or become worthless. In recent years, the Chinese government adopted a series of regulatory actions and issued statements to regulate business operations in China, including those related to the use of variable interest entities, cybersecurity, data security, export control and anti-monopoly concerns. As of the date of this Form 10-Q, we have neither been involved in any investigations on cybersecurity review initiated by any Chinese regulatory authority, nor received any inquiry, notice or sanction. As of the date of this Form 10-Q, no relevant laws or regulations in China explicitly require us to seek approval from the CSRC for any securities listing. As of the date of this Form 10-Q, we have not received any inquiry, notice, warning or sanctions regarding our planned overseas listing from the CSRC or any other Chinese governmental authorities relating to securities listings. However, since these statements and regulatory actions are newly published, official guidance and related implementation rules have not all been issued. It is highly uncertain what potential impact such modified or new laws and regulations will have on our ability to conduct our business, accept investments or list or maintain a listing on a U.S. or foreign exchange.

As of the date of this Form 10-Q, we are not required to seek permissions from the CSRC, the CAC or any other entity that is required to approve our operations in China. Nevertheless, Chinese regulatory authorities may in the future promulgate laws, regulations or implement rules that require us or our subsidiaries to obtain permissions from such regulatory authorities to approve our operations or any securities listing.


Holding Foreign Companies Accountable Act

The HFCA Act was enacted on December 18, 2020. The HFCA Act states that if the SEC determines that a company has filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit such shares from being traded on a national securities exchange or in the over the counter trading market in the United States. On June 22, 2021, the U.S. Senate passed a bill which, if passed by the U.S. House of Representatives and signed into law, would reduce the number of consecutive non-inspection years required for triggering the prohibitions under the HFCA Act from three years to two. On December 2, 2021, the SEC adopted amendments to finalize rules implementing the submission and disclosure requirements in the HFCA Act. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB is unable to inspect or investigate completely because of a position taken by an authority in a foreign jurisdiction. The Consolidated Appropriations Act, 2023, which was signed into law on December 29, 2022, amended the HFCA Act to reduce the number of consecutive non-inspection years required to trigger the trading prohibition under the HFCA Act from three years to two years.

On December 16, 2021, the PCAOB issued a report on its determination that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in mainland China and in Hong Kong because of positions taken by Chinese and Hong Kong authorities in those jurisdictions. The PCAOB has made such determination as mandated under the HFCA Act. Pursuant to each annual determination by the PCAOB, the SEC will, on an annual basis, identify issuers that have used non-inspected audit firms and thus are at risk of such suspensions in the future.

On August 26, 2022, the CSRC, the Ministry of Finance of the PRC, and the PCAOB signed the Protocol, taking the first step toward opening access for the PCAOB to completely inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong. Pursuant to the Protocol,

On December 15, 2022, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigationvacated its 2021 determination that the positions taken by authorities in mainland China and has the unfettered ability to transfer information to the SEC. However, uncertainties still exist as to compliance with the Protocol. Depending on the implementationHong Kong prevented it from inspecting and investigating completely registered public accounting firms headquartered in those jurisdictions. In view of the Protocol, ifPCAOB’s decision to vacate its 2021 determination and until such time as the PCAOB continuesissues any new adverse determination, the SEC has stated that there are no issuers at risk of having their securities subject to be prohibited from conductinga trading prohibition under the HFCA Act. Each year, the PCAOB will reassess its determinations on whether it can inspect and investigate completely audit firms in China, and if, in the future, the PCAOB determines it cannot do so, or if Chinese authorities do not allow the PCAOB complete access for inspections and investigations of PCAOB-registeredfor two consecutive years, companies engaging China-based public accounting firms in China, then China-based companies willwould be delisted pursuant to the HFCA Act despite the Protocol. Therefore, there is no assurance that the Protocol could give relief to China-based companies against the delisting risk from the application of the HFCA Act.

Our auditor, Weinberg & Company, an independent registered public accounting firm headquartered in the United States is not subject to the determinations announced by the PCAOB on December 16, 2021. Our auditor is currently subject to PCAOB inspections and has been inspected by the PCAOB on a regular basis. However, if the PCAOB is unable to inspect the work papers of our accounting firm in the future, such lack of inspection could cause trading in our common stock to be prohibited under the HFCA Act, and as a result, an exchange may determine to delist our common stock. The delisting and the cessation of trading of our common stock, or the threat of our common stock being delisted and prohibited from being traded, may materially and adversely affect the value of your investment.our common stock.


2930Financial Statement Index


Transfer of Cash or Assets

Dividend Distributions

As of the date of this Form 10-Q, none of our subsidiaries have made any dividends or distributions to Remark.

We have never declared or paid dividends or distributions on our common equity. We currently intend to retain all available funds and any future consolidated earnings to fund our operations and continue the development and growth of our business; therefore, we do not anticipate paying any cash dividends.

Under Delaware law, a Delaware corporation’s ability to pay cash dividends on its capital stock requires the corporation to have either net profits or positive net assets (total assets less total liabilities) over its capital. If we determine to pay dividends on any of our common stock in the future, as a holding company, we may rely on dividends and other distributions on equity from our subsidiaries for cash requirements, including the funds necessary to pay dividends and other cash contributions to our stockholders.

Our WFOE’s ability to distribute dividends is based upon its distributable earnings. Current Chinese regulations permit our WFOE to pay dividends to its shareholder only out of its registered capital amount, if any, as determined in accordance with Chinese accounting standards and regulations, and then only after meeting the requirement regarding statutory reserve. If our WFOE incurs debt in the future, the instruments governing the debt may restrict its ability to pay dividends or make other payments to us. Any limitation on the ability of our WFOE to distribute dividends or other payments to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our businesses, pay dividends or otherwise fund and conduct our business. In addition, any cash dividends or distributions of assets by our WFOE to its stockholder are subject to a Chinese withholding tax of as much as 10%.

The Chinese government also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of China. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from our profits, if any. If we are unable to receive all of the revenues from our operations through our China-based subsidiaries, we may be unable to pay dividends on our common stock.


AI Business

ThroughWe generate revenue by using the proprietary data and AI software platform we developed our Remark AI business in the U.S. and the KanKan AI business in the Asia-Pacific region generate revenue by deliveringto deliver AI-based computer vision products, computing devices and software-as-a-service solutions for businesses in many industries. In additionWe continue to the other work that we have ramped up, we continue partneringpartner with top universities on research projects targeting algorithm, artificial neural network and computing architectures which we believe keepswill keep us among the leaders in technology development. Our research team continues to participate in various computer vision competitions at which it wins or ranks near or at the top.

We continue to market Remark AI’s innovative AI-based solutions to customers in the retail, urban life cycle and workplace and food safety markets. We have also begun to expand our AI-based safety solutions to railway customers in the transportation market.

Retail Solutions. Utilizing a client’s existing cameras and IoT devices placed throughout the store, Remark AI’s retail solutions swiftly analyze real-time customer shopping behavior, such as time of store entry and shelf-browsing habits, and provide managers with a customer heatmap that reflects traffic patterns. Purchase history is also analyzed, leading to relevant offers for future purchase conversions, and customers for their continued loyalty through a special VIP status that brings customized promotions and coupons along with attentive customer service. Remark AI’s retail solutions allow retailers and store managers to make better data-driven decisions regarding store layout, item placement, and pricing strategy, all while anonymizing customers’ identities to protect their privacy.

Urban Life Cycle Solutions. We offer and have installed several solutions in what we call the urban life cycle category. Our urban life cycle solutions include our AI community system which assists in building “smart” communities by enhancing community security and safety. We also have AI solutions that help to make schools “smart” by (i) providing an accurate and convenient method for student check-in and check-out, (ii) providing an autonomous method of campus monitoring that enhances students’ safety by, for example, monitoring students for elevated body temperatures that could indicate viral
30Financial Statement Index


infections such as influenza or COVID-19, detecting trespassers, detecting dangerous behaviors or physical accidents that could result in injury, and (iii) monitoring the school kitchen for safety violations.

In traffic management, our solutions assist in monitoring traffic for various violations by automatically detecting, capturing, and obtaining evidence regarding violations such as speeding, running red lights, driving against the flow of traffic and even using counterfeit registration plates. Additionally, our solutions provide constant road-condition monitoring, providing control centers with real-time information on traffic conditions such as areas of congestion or other traffic anomalies.

Workplace and Food Safety Solutions.The monitoring and detection capabilitiesprimary focus of our solutions ensure that workers are practicing established foodbusiness is promoting and facilitating the safety protocols, wearing the proper personal protective equipment,of our customers and complying with local health codes. From commercial kitchens to factories to construction work zones,their customers through our safety-compliance algorithms manage regulatory functions, review hygienic and equipment status while checking and alerting management regarding violations.

Railway Safety Solutions. In railway settings, our product known as the Smart Sentry uses the Smart Safety Platform (the “SSP”),. The SSP, having won numerous industry and government benchmark tests for accuracy and speed, is a specialized version ofleading software solution for using computer vision to detect persons, objects and behavior in video feeds. Real-time alerts from the software platform we developed,SSP allow operations staff to provide intrusion-detection capabilities that allow customers to monitor railroad tracks, rail yards and other sensitive areas around the clock, in all weather conditions and at varying distances. The Smart Sentry, which customers can deploy as an individual unit or as a system of units, detects when pedestrians or vehicles are crossing a railway or entering the railway tracks as a train is approaching, and then alerts customer personnel to the situation so action can be takenrespond rapidly to prevent hazardous incidents from happening. When deployed in multiple-unit systems, each Smart Sentry unit works in concert with the other units to relay warningsany events or activities that give train operators sufficient time to respond to the track intrusions from miles away. Using the Smart Sentry’s high-end cameras and other hardware, the SSP also gathers and analyzes data on railway traffic and weather conditions along various railways to provide valuable, actionable information to railway personnel. In the near future, we expect to add more safety features to Smart Sentry, such as the ability to detect worncan endanger public security or otherwise damaged track and the ability to identify stationary obstacles like fallen rocks or trees.

Biosafety Solutions. We repurposed and improved our existing urban life cycle solution that we were selling to make schools in China “smart” schools to build a product line of high-quality, highly-effective thermal imaging solutions that leverage our innovative software.workplace safety.

We deploy the SSP to integrate with each customer’s IT infrastructure, including, in many cases, cameras already in place at the customer’s location(s). When necessary, we also sell and deploy hardware to create or supplement the customer’s monitoring capabilities. Such hardware includes, among other items, cameras, edge computing devices and/or our Remark AI Thermal Kits to customers needing the ability to scan crowds and areas of high foot traffic for indications that certain persons with elevated temperatures may require secondary screening. Though the kits are semi-customizable, they generally consist primarily of a thermal imaging camera, a calibrating device, a computer to monitor the video feed, supporting equipment and our AI software. Once set up and calibrated, the kits scanSmart Sentry units. The Smart Sentry is a large numbermobile camera unit with a telescoping mast on which a high-quality camera is mounted. Based upon customer needs, the camera may have either standard vision and/or thermal vision capability. The camera works in conjunction with an edge computing device that is also mounted to the unit. The Smart Sentry is an example of people each minute, providing both thermally enhancedhow we incorporate the SSP in modern IT architectural concepts, including edge computing and standard video feeds that allow our customersmicro-service architectures. Edge computing, for example, allows the SSP to evaluate high volumes of peopleconduct expensive computing tasks at distributed locations without requiring large gatherings.

Our Remark AI rPad thermal imaging devices, usually mounted on a wall or a single-post stand, are designed for customers needingdata transmission over the ability to scan individuals on a one-by-one basis in situations where rapid, high-volume scanning is not necessary, such asinternet, thereby dramatically reducing costs while integrating numerous and varied sensors at a customer’s office entrances where employees can be scanned as they enter for indications of an elevated temperature that may require secondary screening. In addition to thermal scanning, we can customize our AI software embedded in the rPad to perform additional safety and security functions including identifying persons for authorized entry.


Other Businesses

Though our focus remains on our AI and data analytics solutions, which produce substantially all of our revenue, we will continue to operate the Bikini.com e-commerce business until such time as we can sell such business in the near future. We also have continued developing a metaverse that we believe can lead to opportunities in other verticals to which we can apply our AI expertise and develop new revenue streams for our investors.distributed locations.

31Financial Statement Index


We customize and sell our innovative AI-based computer vision products and solutions, including the SSP, to customers in the retail, construction, public safety, workplace safety and public sector markets. We have also developed versions of our solutions for application in the transportation and energy markets.


Overall Business Outlook
 
The innovative AITwo primary factors have been affecting our business in recent quarters and data analytics solutionsoccupying our focus as we already sellplan for the future. While we have been dealing with a slow economic recovery in China as municipalities and businesses there try to return to fully-normalized operations following strict preventative measures related to the COVID-19 pandemic, political tensions between the U.S. and China have continued to increase over recent months to a point that such tensions have also impacted our ability to complete projects in China as quickly as we have in the past and as quickly as we had planned during 2023. Management is optimistic that tensions between the U.S. and China will begin to relax after the most-recent summit between such countries’ leaders, but we expect that we may continue to face difficult-to-predict operating results in China for approximately the next 12 months.

While we will continue to serve aswork with customers in China, we have been responding to the backbone of our effortspandemic-related challenges and political tensions by looking for opportunities to expand our business not only in the Asia-Pacific region outside of China, where we believe there still are fast-growth AI market opportunities for our solutions, but alsoas well as by spending increasing amounts of effort over the past several quarters developing business opportunities in the United States, the U.K., and Europe,in Central and South America, where we see a tremendous number of requestsdemand for AI products and solutions in the workplace, government and public safety markets. During the nine months ended September 30, 2023, we began sales in the U.K. and Brazil, while during the three months ended September 30, 2023, we successfully signed initial contracts to expand our sales into Colombia, Malaysia, and India. Given the lack in those three respective countries and in Brazil of AI companies specializing in computer vision, we believe we have a first-mover advantage with regard to targeting the same industries that we have successfully targeted in China and which we have targeted in the U.S. and U.K. In addition, we anticipate expanding sales into the Middle East during the first quarter of 2024.

In conjunction with the geographic diversification of our business, we believe we can more rapidly and more efficiently develop and increase our market presence in the various industries that we have identified as being most important by establishing business relationships with channel partners. To that end, we have been discussing such relationship possibilities with large, established players in the information technology and burgeoning AI space which could provide us with access to their respective online marketplaces and other sales channels as well.

Despite our efforts, the COVID-19 pandemic, as well as economic and geopolitical conditions in some international regions, could continue to affect our business and we cannot be sure what the ultimate effects will be. We will continue to pursue large business opportunities,geographic diversification, but anticipating when, or if, we can close theseon the opportunities in front of us is difficult. QuicklyIn addition, we may face a large number of well-known competitors which would make deploying our software solutions in the market segments we have identified in which we may face a number of large, well-known competitors, is also difficult.

The response to the COVID-19 pandemic will likely continue to adversely affect our business and financial results, as could economic and geopolitical conditions in some international regions, and we do not yet know what will be the ultimate effects on our business. The COVID-19 pandemic caused a broad shift towards remote working arrangements for many businesses worldwide and injected uncertainty and delay into decision-making processes for such businesses. Varying degrees of preventative measures are still in place in China and other parts of the world, including city-wide lockdowns, travel restrictions, closures of non-essential businesses and other quarantine measures. In particular, the preventative measures in China as a result of the Chinese government’s “Zero-COVID” policy have significantly limited the operational capabilities of our China-based subsidiaries. Many cities across large swaths of China have recently been fully or partially locked down for weeks or even months, including economically significant regions such as Shanghai. Such lockdowns have had a material adverse impact on our business and we expect them to continue to have a material adverse impact on our business at least through the third quarter of 2022.

The full extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including resurgences and further spread of existing or new COVID-19 variants, the duration of any remaining preventative measures implemented by domestic and foreign governments, the impact on capital and financial markets and the related impact on the financial circumstances of our customers, all of which are highly uncertain and cannot be predicted. The pandemic-related situation continues to change rapidly, and additional impacts of which we are not currently aware may arise. We are closely monitoring worldwide developments and are continually assessing the potential impact on our business.


Inflation and Supply Chain

Other than the impact of inflation on the general economy, we do not believe that inflation has had a material effect on our operations to date. However, there is a risk that our operating costs could be subject to inflationary pressures in the future, which would have the effect of increasing our operating costs and putcause additional stress on our working capital resources.

WeThe high level of political tension described above has affected our ability to work with certain vendors in a timely manner. Though we have not experienced any supply chain disruptions that have had a material effect onbeen able to complete contracts with our operations to date. As our business begins to expandcustomers in China, such political tension has caused delays in the U.S. based initially onspeed at which we can work with certain vendors to deploy our SSP software,services and complete contracts in China. Also, as we work to increase our sales of computer-vision products and services in the U.S., Europe and South America and thereby geographically diversify our business, we could be subjected to the risk of supply chain disruptions with regard to high-technology products such as servers and related equipment that we use to train our AI software algorithms and which we plan to sell to customers to support operation of the SSP.our computer-vision products and services.


Business Developments During 2022

The COVID-19 pandemic caused renewed lockdowns in China, which made it difficult for us to interact with our clients and vendors. While we were able to complete several larger projects during the first half of 2022, primarily during the first quarter, including construction projects obtained through our China Business Partner and projects related to school campuses, ongoing lockdowns throughout the second and third quarters prevented us from being able to complete as many projects as we otherwise had planned to complete this year.

32Financial Statement Index


Business Developments During 2023

China’s response to the COVID-19 pandemic, known as the Zero-COVID policy, included lockdowns and/or other severe restrictions on business and daily life in China, which made it difficult for us to interact with our clients and vendors through at least December 2022. As described above, such preventative measures, in addition to a high level of political tension between the U.S. and China, have had lingering economic and operational effects which have made it difficult for us to complete as many projects in China during the nine months ended September 30, 2023 as compared to the same period of the previous year. Our customers have only slowly been able to restart stalled projects or begin new ones. The majority of our completed work was related to a large telecommunications provider in China and concrete producers. We completed certain projects in China during the three months ended September 30, 2023 worth approximately $1.4 million, but the agreement has not yet met the criteria for revenue recognition. Cost associated with the projects for which the agreement has not yet met the criteria for revenue recognition was approximately $1.2 million.

Also, during the three months ended September 30, 2023, we successfully signed initial contracts to expand our sales into Colombia, Malaysia, and India. We have not yet recognized any revenue from such new contracts, and we recognize that these are just the first steps into new markets.

The following table presents our revenue categories as a percentage of total consolidated revenue during the three and nine months ended September 30, 20222023 and 2021.2022.
Three Months Ended September 30,Nine Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,
20222021202220212023202220232022
AI-based products and servicesAI-based products and services95 %68 %97 %90 %AI-based products and services95 %95 %96 %97 %
Advertising and otherAdvertising and other%32 %%10 %Advertising and other%%%%


CRITICAL ACCOUNTING POLICIESESTIMATES

During the ninethree months ended September 30, 2022,2023, we made no material changes to our critical accounting policiesestimates as we disclosed them in Part II, Item 7 of our 20212022 Form 10-K.


RESULTS OF OPERATIONS

The following tables summarize our operating results for the three and nine months ended September 30, 2022,2023, and the discussion following the table explains material changes in such operating results compared to the three and nine months ended September 30, 2021.


(dollars in thousands)Three Months Ended September 30, 2022Change
20222021DollarsPercentage
Revenue, including amounts from China Business Partner$2,812 $1,234 $1,578 128 %
Cost of revenue2,459 854 1,605 188 %
Sales and marketing270 882 (612)(69)%
Technology and development41 635 (594)(94)%
General and administrative6,726 5,493 1,233 22 %
Depreciation and amortization43 35 23 %
Interest expense(1,365)(438)(927)212 %
Change in fair value of warrant liability— 411 (411)(100)%
Gain on investment(348)78,917 (79,265)(100)%
Gain on debt extinguishment— 425 (425)(100)%
Other gain (loss), net(493)96 (589)(614)%
Provision for income taxes— 
Net loss(8,924)72,746 (81,670)(112)%
2022.

33Financial Statement Index


(dollars in thousands)(dollars in thousands)Nine Months Ended September 30,Change(dollars in thousands)Three Months Ended September 30,Change
20222021DollarsPercentage20232022DollarsPercentage
Revenue, including amounts from China Business PartnerRevenue, including amounts from China Business Partner$10,037 $9,656 $381 %Revenue, including amounts from China Business Partner$183 $2,812 $(2,629)(93)%
Cost of revenueCost of revenue8,576 5,858 2,718 46 %Cost of revenue254 2,459 (2,205)(90)%
Sales and marketingSales and marketing606 2,281 (1,675)(73)%Sales and marketing340 270 70 26 %
Technology and developmentTechnology and development1,004 3,490 (2,486)(71)%Technology and development768 41 727 1,773 %
General and administrativeGeneral and administrative14,598 10,672 3,926 37 %General and administrative2,843 6,726 (3,883)(58)%
Depreciation and amortizationDepreciation and amortization121 150 (29)(19)%Depreciation and amortization107 43 64 149 %
Total cost and expenseTotal cost and expense4,312 9,539 
Interest expenseInterest expense(5,325)(1,053)(4,272)406 %Interest expense(949)(1,365)416 (30)%
Finance cost related to obligations to issue common stockFinance cost related to obligations to issue common stock(2,086)— (2,086)
Change in fair value of warrant liability— 123 (123)(100)%
Gain (loss) on investment(26,356)78,917 (105,273)(133)%
Gain on debt extinguishment— 425 (425)(100)%
Loss on investmentLoss on investment— (348)348 (100)%
Other gain (loss), netOther gain (loss), net(342)116 (458)(395)%Other gain (loss), net(8)(493)485 (98)%
Provision for income taxesProvision for income taxes(9)18 (200)%Provision for income taxes— (9)(100)%
Net lossNet loss(46,882)65,724 (112,606)(171)%Net loss(7,172)(8,924)1,752 (20)%

(dollars in thousands)Nine Months Ended September 30,Change
20232022DollarsPercentage
Revenue, including amounts from China Business Partner$4,176 $10,037 $(5,861)(58)%
Cost of revenue3,220 8,576 (5,356)(62)%
Sales and marketing1,093 606 487 80 %
Technology and development1,504 1,004 500 50 %
General and administrative8,920 14,598 (5,678)(39)%
Depreciation and amortization178 121 57 47 %
Impairments392 — 392 
Total cost and expense15,307 24,905 
Interest expense(3,351)(5,325)1,974 (37)%
Finance cost related to obligations to issue common stock(6,712)— (6,712)
Loss on investment— (26,356)26,356 (100)%
Other gain (loss), net(14)(342)328 (96)%
Provision for income taxes— (9)(100)%
Net loss(21,208)(46,882)25,674 (55)%





Revenue and Cost of Revenue. During the three and nine months ended September 30, 2023, our project completions slowed in China as business and economic recovery efforts that began after China lifted most of its onerous COVID-19 related restrictions at the end of 2022, we completed larger AI-relatedas well as the noted political tensions between the U.S. and China, continued to make it more difficult than expected for us to complete projects on a steadily increasing pace. As a result of completing fewer projects than expected, revenue lagged behind our performance in the comparable periodssame period of the prior year, includingwhich period included projects associated with our collaborationwork with an unrelated entity (the “China(our China Business Partner”), resulting in $1.9 million and $3.7 million more revenue, respectively. Decreases in U.S. revenue during the three months ended September 30, 2022 of $0.2 million from advertising related to the daily fantasy sports project and approximately $0.1 million from our e-commerce business partially offset the increase in revenue from China. Decreases in U.S. revenue duringPartner).

During the nine months ended September 30, 2022 of approximately $2.8 million from AI data intelligence services and advertising related2023, we were unable to a daily fantasy sports project that was not repeatedcomplete as many projects in China as we did in the currentsame period of the prior year, and $0.4 million from our biosafety businessprimarily due to a decline in demand, partially offset the increased revenue from China.slow and methodical business and economic recovery efforts that are ongoing after China lifted most of its onerous COVID-19 related restrictions at the end of 2022.

The increase in costCost of revenue during the three and nine months ended September 30, 2022 was related to our completion of larger projects2023 decreased, in China as described above, partially offset by the decrease in cost of revenue associatedconjunction with the U.S. revenue decreases in project completions described above.

Sales and marketing.The decreaseaddition in late 2022 of three new personnel, including two executive positions, on our sales team caused an increase of $0.3 million in payroll and marketingrelated expense during the three and nine months ended September 30, 2022 resulted because the prior year to date included $0.6 million and $1.9 million, respectively, that we advanced to our China Business partner, and such amount was classified as marketing expense. During the nine months ended September 30, 2022, the $1.9 million was partially offset by approximately $0.6 million resulting from our completion of orders from a client that resulted from our joint efforts with our China Business Partner. Because we had provided money to our China Business Partner in 2021 for the business development efforts that resulted in the customer orders, we had recorded the $0.6 million as an offset to the expense. Changes in other expense categories, including shares-based compensation expense and payroll and benefits expense, contributed to the overall change in sales and marketing expense but were individually immaterial and not representative of material trends.2023.

Technology and development.Development. During the three months ended September 30, 2022, we reclassified a refundable tax credit we received from the government of the United Kingdom resulting from our research and development activities in its jurisdiction from Other gain to technology and development expense. Consulting fees decreased $1.3 millionThe current-year tax credit was recorded in a previous quarter during 2023. A modest increase in consulting related to our research and development activities also contributed to the nineincrease in technology and development expense.

During the three months ended September 30, 2022, because we no longer needed certain third-party services after2023, an increase in consulting related to our acquisition,research and development activities caused the increase in an immaterial business combination, of our U.K. subsidiary. Additionally, the tax credit from the United Kingdom reduced the expensetechnology and share-based compensation expense decreased $0.4 million during the same period.



development expense.

General and administrative. During the three and nine months ended September 30, 2022, as a result2023, we did not have to record any reserve for doubtful accounts, while during the comparable period of the ongoing lockdowns related to China’s Zero-COVID policy,prior year we have had to re-evaluate the amounts receivable from customers based on what was then recent information and, as a result, we increased our reserve for doubtful accounts by $2.3 million. Additionally, weWe experienced an increasea decrease of approximately $0.8 million in legal and other professional fees primarily in connection withbecause the three months ended September 30, 2022 included expense related to financings that were completed after the end of the quarter and the filing of amendments to registration statements whereas we did not have similar activity during the three months ended September 30, 2023. Also contributing to the overall decrease in general and increases of $0.7 million and $1.7 million, respectively, in certain business development expenses as we work to expand our client base. The increases were partially offset byadministrative expense was a decrease of $2.8$0.3 million and $1.8 million, respectively, in certain expenses related to business development, including short-term work space rentals. Finally, our share-based compensation expense.expense decreased by $0.5 million due to a large batch of stock options with a grant date of July 8, 2021 becoming fully expensed in January 2023, in comparison to having three months of expense recognition during the three months ended September 30, 2022 and due to the decrease in the number of outstanding China Cash Bonuses.

During the nine months ended September 30, 2023, we did not have to record any reserve for doubtful accounts, while during the comparable period of the prior year we had to re-evaluate the amounts receivable from customers based on what was then recent information and, as a result, we increased our reserve for doubtful accounts by $2.3 million. We experienced a decrease of approximately $0.8 million in legal and other professional fees primarily because the nine months ended September 30, 2022 included expense related to financings and the filing of amendments to registration statements whereas we did not have similar activity during the three months ended September 30, 2023. Also contributing to the overall decrease in general and administrative expense was a decrease of $1.5 million in certain expenses related to business development, including short-term work space rentals. Finally, our share-based compensation expense decreased by $1.3 million due to a large batch of stock options with a grant date of July 8, 2021 becoming fully expensed in January 2023, in comparison to having nine months of expense recognition during the nine months ended September 30, 2022 our payroll and benefits increased $0.7due to the decrease in the number of outstanding China Cash Bonuses.

Impairments. During the nine months ended September 30, 2023, we determined that certain costs that we had capitalized to software development in progress would no longer be recoverable and we recorded an impairment of approximately $0.2 million. Also, we recorded an impairment of approximately $0.2 million related to certain prepaid expense amounts which were deemed unrecoverable

Interest expense. We executed the Original Mudrick Loan Agreements in December 2021, pursuant to which we obtained the Original Mudrick Loans in the aggregate principal amount of $30.0 million. The Mudrick Loans bore interest at 16.5% through July 2022 and, following an amendment, now bear interest at 18.5%. The Mudrick Loans were the primary cause of the increase in interest expense during the three and nine months ended September 30, 2022. The same period of the prior year included significantly less debt principal outstanding, with such principal bearing lower interest rates than on the Mudrick Loans. Included as part of interest expense duringDuring the nine months ended September 30,



2022, waswe recorded in interest expense approximately $2.2 million of amortization of debt discount and debt issuance cost related to the Original Mudrick Loans, as well as a $0.3 millionbut did not have any such amortization during the nine months ended September 30, 2023 because the debt discount and debt issuance cost were fully amortized during 2022. Interest expense also decreased because significantly less debt principal was outstanding on the Original Mudrick Loans during the three and nine months ended September 30, 2023 than during the same period of the prior year, even though the interest rate had increased from 16.5% to 20.5%. Partially offsetting the decreases in interest expense was the amendment and extension fee relatedof approximately $0.8 million we recorded in relation to our entry on March 14, 2023 into the First Amendment to theNew Mudrick Loan Agreements.Agreement described, along with the Original Mudrick Loan Agreements, in Note 10 in the Notes to Unaudited Condensed Consolidated Financial Statements included in this Form 10-Q.

Gain (loss)Finance Cost Related to Obligations to Issue Common Stock. The finance cost during the three and nine months ended September 30, 2023 resulted from the establishment and remeasurement of obligations to issue our common stock that we incurred in relation to the debentures we issued to Ionic in 2022 and 2023, as well as the ELOC Advances we received from Ionic, all of which is described in Note 11 in the Notes to Unaudited Condensed Consolidated Financial Statements included in this Form 10-Q. We had no similar transactions during the three and nine months ended September 30, 2022.

Loss on investment. On July 1, 2021, as the result of a business combination involving a U.S.-based venture, Sharecare, Inc. (“Legacy SharecareSharecare”) and Falcon Capital Acquisition Corp., a special purpose acquisition company, the common stock of the surviving entity of such business combination (“New Sharecare,Sharecare”) became listed on the Nasdaq Stock Market LLC and our equity in Legacy Sharecare converted into cash and shares of publicly traded common stock of New Sharecare. As a result of the common stock of New Sharecare being traded on a national securities exchange, we were able to remeasure our investment at fair value. Since July 1, 2021, the value of the New Sharecare stock hassteadily declined, significantly, which caused the decrease from a large gainlosses on investment during the three and nine months ended September 30, 2021,2022. On July 11, 2022, we delivered our remaining 6,250,000 shares of New Sharecare to the small gain during the three months ended September 30, 2022our lender at their request and, the loss of $26.4 millionas a result, we did not maintain investments during the nine months ended September 30, 2022.

Gain on debt extinguishment. During the third quarter of 2021, we received notification that our previously-outstanding Paycheck Protection Program loan had been forgiven, resulting in a gain of approximately $0.4 million.

Change in fair value of warrant liability. After reclassifying our warrants to equity on August 31, 2021, we are no longer required to routinely remeasure them at fair value.2023.

Other gain (loss)., net. Other loss duringDuring the nine months ended September 30, 2022, increased over the other gain we recorded during the same period of the prior year because we accrued $0.4 million of liquidated damages during the second quarter of 2022 related to the Armistice Resale Registration Statement which became effective after the time frame during which we were required to ensure it became effective. We had no similar activity during the nine months ended September 30, 2023.


LIQUIDITY AND CAPITAL RESOURCES
 
Overview
 
During the nine months ended September 30, 2022,2023, and in each fiscal year since our inception, we have incurred net losses which have resulted in a stockholders’ deficit of $14.7$32.9 million as of September 30, 2022.2023. Additionally, our operations have historically used more cash than they have provided. Net cash used in operating activities was $13.6$9.1 million during the nine months ended September 30, 2022.2023. As of September 30, 2022,2023, our cash balance was $0.4$0.3 million. Our history of recurring operating losses, working capital deficiencies and negative cash flows from operating activities give rise to, and management has concluded that there is, substantial doubt regarding our ability to continue as a going concern.


Mudrick Loans

On December 3, 2021, we entered into the Original Mudrick Loan Agreements pursuant to which we incurred the Original Mudrick extended credit to us consisting of term loansLoans in the aggregate principal amount of $30.0 million. The Original Mudrick Loans as amended byinitially bore interest at 16.5% per annum until the First Amendment, bearoriginal maturity date of July 31, 2022 and, following an amendment we entered into with Mudrick in August 2022, bore interest at 18.5% per annum. The amendment also extended the maturity date of the Original Mudrick Loans from July 31, 2022 to October 31, 2022. However, we did not make the required repayment of the Original Mudrick Loans by October 31, 2022, which constituted an event of default under the Original Mudrick Loans and triggered an increase in the interest rate under the Original Mudrick Loans to 20.5%.

On March 14, 2023, we entered into the New Mudrick Loan Agreement pursuant to which all of the Original Mudrick Loans were cancelled in exchange for the New Mudrick Notes in the aggregate principal amount of approximately $16.3 million. The New Mudrick Notes bear interest at a rate of 20.5% per annum, (originally 16.5% per annum), which isshall be payable on the last business day of each month.month commencing on May 31, 2023. The interest rate will increase by 2% and the principal amount outstanding under the New Mudrick Notes and any unpaid interest thereon may become immediately due and payable upon the occurrence of any



event of default under the New Mudrick Loan Agreement. All amounts outstanding under the New Mudrick Loans, as amended,Notes, including all accrued and unpaid interest, will be due and payable in full on October 31, 2022 (originally due on July 31, 2022). 2023. See Note 10 in the Notes to Unaudited Condensed Consolidated Financial Statements included in this Form 10-Q for additional information regarding the New Mudrick Notes.

To secure the payment and performance of the obligations under the Original Mudrick Loan Agreements and the New Mudrick Loan Agreement, we, together with the Guarantors, have granted to TMI Trust Company, as the collateral agent for the benefit of Mudrick, a first priority lien on, and security interest in, all assets of Remark and the Guarantors, subject to certain customary exceptions. The Mudrick Loan Agreements contain representations, warranties, events of default, indemnifications and other provisions customary for financings of this type. The occurrence of any event of default



under the Mudrick Loan Agreements may result in the principal amount outstanding and unpaid interest thereon becoming immediately due and payable. In connection with our entry into the Original Mudrick Loan Agreements, we paid to Mudrick an upfront fee equal to 5.0% of the amount of the Original Mudrick Loans, which amount was netted against the drawdown of the Original Mudrick Loans. We recorded the upfront fee as a debt discount of $1.5 million, and recorded debt issuance cost totaling $1.1 million. We amortized the discount on the Original Mudrick Loans and the debt issuance cost over the life of the Original Mudrick Loans and, during the nine monthsyear ended September 30,December 31, 2022, we amortized $2.2 million of such discount and debt issuance cost.

On August 3, 2022, In consideration for the amendment we entered into the First Amendment with Mudrick pursuant to which, Mudrick agreed, among other things, to (i) waive certain existing events of default under the Mudrick Loan Agreements, (ii) extend the original July 31,in August 2022, maturity date to October 31, 2022 (provided, however, that if we prepay the principal amount of the loans in an amount of at least $5 million, the maturity date will be automatically extended to November 30, 2022), and (iii) defer payment of interest for the month of July 2022 to August 31, 2022. In addition, on and after the effective date of the First Amendment, the outstanding loans under the Mudrick Loan Agreements will bear interest at 18.5% per annum, payable on the last business day of each month commencing on August 31, 2022. We have also agreed to commence marketing and sale efforts with respect to our Bikini.com business. In consideration for Mudrick’s agreement to enter into the First Amendment and extend the maturity date, we agreed to paypaid Mudrick an amendment and extension paymentfee in the amount of 2.0% of the then unpaid principal balance of the loans outstanding as of the date of the First Amendment, orOriginal Mudrick Loans, which was approximately $0.3 million, which was addedby adding such amount to the principal balance of the loans as of the effective date of the First Amendment.Original Mudrick Loans.

On October 6, 2022, we also entered into the Mudrick Waiver to the Mudrick Loan Agreements. Pursuant to the Mudrick Waiver, Mudrick agreed, among other things, to (i) waive certain existing events of default under the Mudrick Loan Agreements, (ii) defer payment of interest for the months of July, August and September 2022 to October 6, 2022, the closing date of the Debenture Purchase Agreement, and (iii) consent to the issuance of the Debenture and the other transactions contemplated by the Debenture Purchase Agreement. In connection with the Mudrick Waiver, we became a party to a Subordination and Intercreditor Agreement with Mudrick and Ionic, pursuant to which Ionic agreed, among other things, that all of our obligations to Ionic under the Debenture will be fully and unconditionally junior and subordinate in right of cash payment to the prior satisfaction in full of our obligation to Mudrick.

We did not make the required repayment of the outstanding loans under the Mudrick Loan Agreements by October 31, 2022, the maturity date. This constitutes an event of default for which we have not received a waiver as of the date of this Form 10-Q. While we are actively engaged in discussions with Mudrick regarding a resolution of the event of default, we cannot provide any assurance that we will be successful in obtaining a waiver or that Mudrick will forebear from taking any enforcement actions against us. As of the date of this Form 10-Q, the principal amount outstanding, together with interest on the unpaid principal balance of the New Mudrick Loan,Notes, is $14.4approximately $17.4 million.


Ionic Transactions

On October 6, 2022, we entered into the 2022 Debenture Purchase Agreement with Ionic, pursuant to which we issued the 2022 Debenture in the original principal amount of $2,778,000 to Ionic for a purchase price of $2,500,000. The Debenture accrues interest at a rate of 8% per annum. The interest rate on the Debenture increases to a rate of 15% per annum if the Debenture is not fully paid or converted by February 6, 2023 or upon the occurrence of certain trigger events, including, without limitation, the suspension from trading or the delisting of our common stock from Nasdaq and the occurrence of any material adverse effect. In addition, if the Debenture is not fully paid or converted by the February 6, 2023, the original principal amount of the Debenture will be deemed to have been $3,334,000 from the issuance date. The Debenture matures on June 6, 2023. The terms of the Debenture are further described in Note 16 in the Notes to Unaudited Condensed Consolidated Financial Statements included in this report.$2.5 million.

Also,In connection with the 2022 Debenture, on October 6, 2022, we also entered into the ELOC Purchase Agreement, with Ionic, which provides that, upon the terms and subject to the conditions and limitations set forth therein, we have the right to direct Ionic to purchase up to an aggregate of $50,000,000$50.0 million of shares of our common stock over the 36-month term of the ELOC Purchase Agreement. Under the ELOC Purchase Agreement, after the satisfaction of certain commencement conditions, including, without limitation, the effectiveness of the Ionic Resale Registration Statement and that the Debenture shall have been fully converted into shares of common stock or shall otherwise have been fully redeemed and settled in all respects in accordance with the terms of the Debenture, we have the right to present Ionic with a Purchase Noticepurchase notice directing Ionic to purchase any amount up to $3,000,000$3.0 million of our common stock per trading day, at the Purchase Pricepurchase price equal to 90% (or 80% if our common stock is not then trading on Nasdaq) of the average of the 5five lowest VWAPs of our common stock over a specified measurement period. With each purchase under the ELOC Purchase Agreement, we are required to deliver to Ionic an additional number of shares equal to 2.5% of the number of shares of common stock deliverable upon such purchase. See

Note 16
On November 7, 2022, we entered into an amendment to the 2022 Debenture Purchase Agreement with Ionic, pursuant to which we and Ionic agreed to amend and restate the 2022 Debenture to provide that (i) in no event will the conversion price under the 2022 Debenture be below a floor price of $0.10 (such price, as may be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction, the “Floor Price”), and (ii) in the Notesevent the actual conversion price is less than the Floor Price, (A) Ionic will be entitled to Unaudited Condensed Consolidated Financial Statements included in this report for additional detail regardingthat number of settlement conversion shares issuable with an assumed conversion price equal to the Floor Price, and (B) we will be required to make a cash payment to Ionic on or prior to the maturity date of an amount that is calculated by subtracting the number of shares of common stock issuable at an assumed conversion price equal to the Floor Price from the number of shares of common stock issuable at the actual conversion price, multiplied by a price equal to the average of the ten lowest VWAPs during the specified measurement period.

On January 5, 2023, we and Ionic entered the Letter Agreement which amended the ELOC Purchase Agreement. Under the Letter Agreement, the parties agreed, among other things, to (i) amend the floor price below which Ionic will not be required to buy any shares of our common stock under the ELOC Purchase Agreement from $0.25 to $0.20, determined on a post-reverse split basis, (ii) amend the per share purchase price for purchases under the ELOC Purchase Agreement to 90% of the average of the two lowest daily VWAPs over a specified measurement period, which will commence at the conclusion of the applicable measurement period related to the 2022 Debenture and (iii) waive certain requirements in the ELOC Purchase Agreement to allow for a one-time $0.5 million purchase under the ELOC Purchase Agreement.

On March 14, 2023, we entered into the 2023 Debenture Purchase Agreement with Ionic pursuant to which we authorized the issuance and sale of two convertible subordinated debentures in the aggregate principal amount of approximately $2.8 million for an aggregate purchase price of $2.5 million. The first debenture is in the original principal amount of approximately $1.7 million for a purchase price of $1.5 million, which was issued on March 14, 2023, and the second debenture is in the



original principal amount of approximately $1.1 million for a purchase price of $1.0 million, which was issued on April 12, 2023.

On September 15, 2023, we and Ionic entered into a letter agreement (the “September 2023 Letter Agreement”) which amends the Purchase Agreement, dated as of October 6, 2022, by and between Remark and Ionic, and as previously amended on January 5, 2023 (the “ELOC Purchase Agreement”). The September 2023 Letter Agreement superceded two previous letter agreements we entered into with Ionic, one in July 2023 and another in August 2023.

Under the September 2023 Letter Agreement, the parties agreed, among other things, to (i) allow Remark to deliver one or more irrevocable written notices (“Exemption Purchase Notices”) to Ionic in a total aggregate amount not to exceed $20.0 million, which total aggregate amount shall be reduced by the aggregate amount of previous Exemption Purchase Notices, (ii) amend the per share purchase price for purchases under an Exemption Purchase Notice to 80% of the average of the two lowest daily volume-weighted average prices (“VWAPs”) over a specified measurement period, (iii) amend the definition of the specified measurement period to stipulate that, for purposes of calculating the final purchase price, such measurement period begins the trading day after Ionic pays Remark the amount requested in the purchase notice, while the calculation of the dollar volume of Remark common stock traded on the principal market to determine the length of the measurement period shall begin on the trading day after the previous measurement period ends, iv) that any additional Exemption Purchase Notices that are not in accordance with the terms and provisions of the Purchase Agreement shall be subject to Ionic’s approval, v) to amend section 11(c) of the ELOC Purchase Agreement to increase the Additional Commitment Fee from $0.5 million to $3.0 million and vi) that by September 29, 2023, the parties will amend the Debenture Transaction Documents to include a so-called Most Favored Nation provision that will provide Ionic with necessary protection against any future financing, settlement, exchange or other transaction whether with an existing or new lender, investor or counterparty, and that, if such amendment is not made by September 29, 2023, the Additional Commitment Fee shall be further increased to approximately $3.8 million.

See Note 11 in the Notes to Unaudited Condensed Consolidated Financial Statements included in this Form 10-Q for additional detail on the Ionic transactions.


General

Our history of recurring operating losses, working capital deficiencies and negative cash flows from operating activities give rise to substantial doubt regarding our ability to continue as a going concern.

We intend to fund our future operations and meet our financial obligations through revenue growth from our AI offerings, as well as through sales of our thermal-imaging products. We cannot, however, provide assurance that revenue, income and cash flows generated from our businesses will be sufficient to sustain our operations in the twelve months following the filing of this Form 10-Q. As a result, we are actively evaluating strategic alternatives including debt and equity financings.

Conditions in the debt and equity markets, as well as the volatility of investor sentiment regarding macroeconomic and microeconomic conditions (in particular, as a result of the COVID-19 pandemic, global supply chain disruptions, inflation and other cost increases, and the geopolitical conflict in Ukraine), will play primary roles in determining whether we can successfully obtain additional capital.

A variety of factors, many of which are outside of our control, affect our cash flow; those factors include the effects of the COVID-19 pandemic, regulatory issues, competition, financial markets and other general business conditions. Based on financial projections, we believe that we will be able to meet our ongoing requirements for at least the next 12 months with existing cash and based on the probable success of one or more of the following plans:

develop and grow new product line(s)

obtain additional capital through equity issuances.

However, projections are inherently uncertain and the success of our plans is largely outside of our control. As a result, there is substantial doubt regarding our ability to continue as a going concern, and we may fully utilize our cash resources prior to December 31, 2022.2023.





Cash Flows - Operating Activities
 
During the nine months ended September 30, 2022,2023, we used $3.5$4.6 million moreless cash in operating activities than we did during the same period of the prior year. The increasedecrease in cash used in operating activities is primarily the result of the timing of payments related to elements of working capital.


Cash Flows - Investing Activities
 
Investing activities during the nine months ended September 30, 2023 were de minimis, while the same period during 2022 provided $6.3 million in proceeds from the sale of a portion of our marketable securities, compared to $2.3 million received in the same period of 2021 from the transaction in which Legacy Sharecare became New Sharecare.securities.


Cash Flows - Financing Activities

During the nine months ended September 30, 2023, we received $2.5 million from Ionic in exchange for the issuance of convertible debentures, and Ionic also advanced us an aggregate of $7.0 million under the ELOC Purchase Agreement for which we issued 2,641,173 shares of our common stock and for which we expect to issue another estimated 978,168 shares of our common stock. Also during the nine months ended September 30, 2023, we received $1.0 million of advances from senior management representing various operating expense payments and repaid $1.1 million of advances from senior management. During the same period of 2022, we repaid $6.2 million of the Original Mudrick Loans and received $2.4 million of advances from senior management and repaid $1.5 million of advances from senior management representing various operating expense payments made on our behalf, while the prior year period’s financing activity included $4.8 million of net debt proceeds plus $5.5 million of proceeds from issuances of our common stock shares.behalf.


Off-Balance Sheet Arrangements

We currently have no off-balance sheet arrangements.





Recently Issued Accounting Pronouncements
 
Please refer to Note 2 in the Notes to Unaudited Condensed Consolidated Financial Statements included in this report for a discussion regarding recently issued accounting pronouncements which may affect us.


ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Not applicable.


ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain a set of disclosure controls and procedures designed to provide reasonable assurance that the information we must disclose in reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. We designed our disclosure controls with the objective of ensuring we accumulate and communicate this information to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under Exchange Act, as of the end of the period covered by this report. Based upon that evaluation, our management, including our principal executive officer and principal financial officer, concluded that, because of the material weaknesses in our internal control over financial reporting related to: (i)



insufficient documentary evidence that we had reviewed information underlying manual journal entries at a sufficient level of detail, (ii) insufficient documentation of our consideration of appropriate revenue recognition criteria for certain contracts arising from our AI business in China, (iii) an aggregation of deficiencies in our monitoring and activity-level controls related to processes in our AI business in China including accounts payable, accrued liabilities, payroll and fixed assets, and (iv) failure to retain documentary evidence of all inventory purchases and the insufficient evaluation of the impact of discounted sales transactions on the valuation of our inventory, all of which we described in our 20212022 Form 10-K, our disclosure controls and procedures were not effective at a reasonable assurance level as of September 30, 2022.2023.


Changes in Internal Control over Financial Reporting

In our 20212022 Form 10-K, we disclosed that management had determined that material weaknesses in our internal control over financial reporting (described above) existed. As of the date of this report, the implementation of the plan developed by management to remediate the underlying causes of the material weaknesses and improve the design and operating effectiveness of internal control over financial reporting and our disclosure controls continues. Such implementation has been slowed by various factors, including the COVID-19 pandemic. As a result, there was no change in our internal control over financial reporting during such periodthe three months ended September 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II - OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

None.


ITEM 1A.    RISK FACTORS




Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors set forth below together withfollowing risks and the risk factors discussed in Part I, Item 1A of our 20212022 Form 10-K, together with all the other information in this Form 10-Q, including our unaudited condensed financial statements and notes thereto, which could materially affect our business, financial condition or operating results. The risks described below and in our 20212022 Form 10-K are not the only risks we face. Additional risks and uncertainties that we are unaware of may become important factors that affect us. If any of these risks actually occur, our business, financial condition or operating results may suffer, the trading price of our common stock could decline, and you may lose all or part of your investment. The following information updates, and should be read in conjunction with the information disclosed in Part I, Item 1A, “Risk Factors,” contained in our 2022 Form 10-K. Except as disclosed below, there have been no material changes from the risk factors disclosed in our 2022 Form 10-K.


We have a history of operating losses and we may not generate sufficient revenue to support our operations.

During the year ended December 31, 2022, and in each fiscal year since our inception, we have incurred net losses and generated negative cash flow from operations, resulting in an accumulated deficit of $(388.5) million as of December 31, 2022 and an accumulated deficit of $(409.7) million as of September 30, 2023. In addition, for the nine months ended September 30, 2023, we had a net loss of $(21.2) million.

We cannot provide assurance that revenue generated from our businesses will be sufficient to sustain our operations in the long term. As a result, we are actively evaluating strategic alternatives including debt and equity financings. Should we fail to successfully implement our plans described herein, such failure would have a material adverse effect on our business, including the possible cessation of operations.

Conditions in the debt and equity markets, as well as the volatility of investor sentiment regarding macroeconomic and microeconomic conditions (in particular, as a result of the COVID-19 pandemic, global supply chain disruptions, inflation and other cost increases, and the geopolitical conflict in Ukraine) will play primary roles in determining whether we can successfully obtain additional capital. We cannot be certain that we will be successful at raising capital, whether in an equity financing or debt financing, on commercially reasonable terms, if at all. In addition, if we obtain capital by issuing equity, such transaction(s) may dilute existing stockholders.
40Financial Statement Index




We may not have sufficient cash to repay our outstanding senior secured indebtedness.

As of September 30, 2023, the entire aggregate principal amount of $16.3 million remained outstanding under the New Mudrick Notes, which became due and payable in full on October 31, 2023. Our concentrationavailable cash and other liquid assets are currently not sufficient to pay such obligations in full. If we do not pay the New Mudrick Notes in full on the scheduled maturity date, Mudrick will have available to them all rights under the New Mudrick Loan Agreements and applicable law, which include, without limitation, foreclosing on the collateral securing the New Mudrick Notes. Mudrick’s exercise of customersany such rights could have a material adverse effect on our financial condition.

We did not make required repayments of the outstanding loans under the New Mudrick Loan Agreement that were due beginning on June 30, 2023, which constitute events of default for which we have not received a waiver as of the date of this Form 10-Q. While we are actively engaged in discussions with Mudrick regarding a resolution of the events of default and have made progress in such discussions, we cannot provide any assurance that we will be successful in obtaining a waiver or that Mudrick will continue to forebear from taking any enforcement actions against us.

Our concentration
We are dependent on a small number of customers couldfor a large percentage of our revenue.

We have a material adverse effect on us. Duringconcentration in the volume of business we transacted with customers, as during the nine months ended September 30, 2022,2023, two of our customers represented about 28% and 24% of our revenue, respectively, while during nine months ended September 30, 2022, two customers represented about 55% and 23%, respectively, of our revenue for such period. During the nine months ended September 30, 2021, our two largest customers represented about 32% and 21%, respectively, of our revenue for such period.revenue. At September 30, 2022,2023, accounts receivable from two of our customers represented about 32%12% and 18%12%, respectively, of our gross accounts receivable, while at December 31, 2021,2022, accounts receivable from our three largest customers represented about 25%23%, 24%16% and 10%, respectively, of our gross accounts receivable. This concentration of customers leaves us exposed to the risks associated with theThe loss of one or moreany of these significantlarge customers which would materially and adversely affecthave a material adverse impact on our revenues and results of operations.financial results.


Our failure to meet the continued listing requirements of the Nasdaq Stock Market could result in a delisting of our common stock.

On April 27, 2023, we received a written notice from the Nasdaq Listing Qualifications Department notifying us that, pursuant to Nasdaq Listing Rule 5550(b)(3), we are required to maintain a minimum of $500,000 in net income from continuing operations in the most recently completed fiscal year, or two of the last three fiscal years (the “Net Income Standard”). Since our 2022 Form 10-K reported net loss from continuing operations, and as of April 25, 2023, we did not meet the alternative continued listing standards (collectively, with the Net Income Standard, the “Continued Listing Standards”) under Nasdaq Listing Rule 5550(b) of a minimum stockholders' equity of $2.5 million or minimum market value of listed securities of $35 million, we no longer comply with the Continued Listing Standards. In accordance with Nasdaq Listing Rule 5810(c)(2)(A), on June 12, 2023 we submitted a plan to regain compliance with the Continued Listing Standards to the Nasdaq Listing Qualifications Department. On July 24, 2023, the Nasdaq Listing Qualifications Department notified us that it was granting us until October 24, 2023 (the “Extension Period”) to file a report with the SEC and Nasdaq stating that we have successfully executed our plan to regain compliance with the Continued Listing Standards and that we did in fact regain such compliance. We were not able to regain compliance with the Continued Listing Standards by October 24, 2023 and, on October 26, 2023, we received a staff determination letter from Nasdaq indicating that we did not regain compliance with the Continued Listing Standards and that, unless we request an appeal of Nasdaq’s determination, our common stock was subject to delisting.

We appealed Nasdaq’s delisting determination to a Hearings Panel (the “Panel”) and were notified by Nasdaq that we have been granted a hearing with the Panel on February 1, 2024.

Our failure to meet the continued listing requirements in the future could result in a delisting of our common stock. A delisting could harm our ability to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors, customers and employees and potential loss of business development opportunities. A delisting from Nasdaq could adversely affect our ability to raise additional financing through the public or private sale of equity securities, would significantly impact the ability of investors to trade our securities and would negatively impact the value and liquidity of our common stock.





ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES, AND USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES

OnWe did not sell any equity securities during the quarter ended September 2, 2022,30, 2023 in transactions that were not registered under the Securities Act other than as previously disclosed in our filings with the SEC and as described below.

Between July 1, 2023 and September 30, 2023, we issued 1,250,0002,702,589 shares of common stock to Ionic Ventures, LLC for advances made pursuant to the ELOC Purchase Agreement between July 1, 2023 and September 30, 2023, we issued 300,000 shares of our common stock to Ionic Ventures, LLC to fulfil our obligations as a result of our failure to meet the filing and effectiveness deadlines specified in the Registration Rights Agreement, and we issued 97,000 shares of our common stock to Ionic Ventures, LLC in partial fulfillment of our obligations pursuant to the 2023 Debentures.

We made the offer and sale of securities in the above-described private placement in reliance upon an exemption from registration requirements pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended, based upon representations made to us by the investor in a purchase agreement we entered into with a fair value of $0.5 million to a vendor in exchange for services performed.the investor.


ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

We did not make the required repaymentrepayments of the outstanding loans under the New Mudrick Loan Agreements by October 31, 2022, the maturity date. This constitutes an eventAgreement that were due beginning on June 30, 2023, which constitute events of default for which we have not received a waiver as of the date of this Form 10-Q. While we are actively engaged in discussions with Mudrick regarding a resolution of the eventevents of default and have made progress in such discussions, we cannot provide any assurance that we will be successful in obtaining a waiver or that Mudrick will continue to forebear from taking any enforcement actions against us. As of the date of this Form 10-Q, the principal amount outstanding, together with interest on the unpaid principal balance of the Mudrick Loan, is $14.7approximately $17.4 million.


ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.


ITEM 5.    OTHER INFORMATION INFORMATION

None.On November 18, 2023, we and Ionic entered into a letter agreement (the “November 2023 Letter Agreement”) which, among other things, amends the Subordinated Convertible Debenture, dated as of March 14, 2023, by and between Remark and Ionic (the “First 2023 Debenture”).


The November 2023 Letter Agreement amends the First 2023 Debenture to include language that requires us to notify Ionic if we enter into any new debt agreement after November 18, 2023 or modify any debt agreement that existed at November 18, 2023. If Ionic determines that the terms of such new or modified agreements are preferable to the terms of the First 2023 Debenture, Ionic can give us written notice to amend, within five days, the terms of the First 2023 Debenture, excluding principal and interest, to give Ionic the benefit of such preferable terms.



ITEM 6.    EXHIBITS
Incorporated Herein
By Reference To
Exhibit NumberDescriptionDocumentFiled OnExhibit Number
S-111/07/20224.8
DEF 14A04/29/2022N/A
8-K08/08/202210.1
8-K10/11/202210.1
8-K10/11/202210.2
8-K10/11/202210.3
8-K10/11/202210.4
8-K10/11/202210.5
S-111/07/202210.2
101The following financial statements from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021; (ii) Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2022 and 2021; (iii) Unaudited Condensed Consolidated Statements of Stockholders’ Deficit for the three and nine months ended September 30, 2022 and 2021; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021; and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
104The cover page from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL (included as Exhibit 101).
Incorporated Herein
By Reference To
Exhibit NumberDescriptionDocumentFile NumberFiled OnExhibit Number
8-K001-3372012/30/20143.1
8-K001-3372001/12/20163.1
8-K001-3372006/08/20163.1
8-K001-3372004/11/20173.1
8-K001-3372007/09/20213.1
8-K001-3372012/21/20223.1
8-K001-3372002/13/20153.1
8-K001-3372007/18/202310.1
8-K001-3372008/16/202310.1
8-K001-3372009/21/202310.1
101.INS*Inline XBRL Instance Document
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document



Incorporated Herein
By Reference To
Exhibit NumberDescriptionDocumentFile NumberFiled OnExhibit Number
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*XBRL Taxonomy Extension Presentation Linkbase Document
104*The cover page from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL (included as Exhibit 101).

*Filed herewith



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
REMARK HOLDINGS, INC.
Date:November 14, 202220, 2023By:/s/ Kai-Shing Tao
Kai-Shing Tao
Chairman and Chief Executive Officer
(principal executive, financial and accounting officer)